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Résumé 
Comprendre les événements paracriniens qui régulent la fertilité chez la vache est 
nécessaire non seulement en raison de l'importance agricole de cette espèce, mais aussi 
pour son utilisation potentielle comme modèle chez l’humain. L'oxyde nitrique (NO), un 
gaz de radicaux libres, a été impliqué dans la croissance folliculaire et l'ovulation chez 
les rongeurs et d'autres espèces, mais chez la vache c’est une énigme fascinante : le NO 
est produit par les cellules de la granulosa bovine et est régulé par la FSH, mais la 
présence et le profil d'expression des enzymes responsables de la synthèse de NO (NOS) 
dans les cellules de la granulosa tout au long de la croissance folliculaire ne sont pas 
claires. Les objectifs de cette thèse sont: (1)  élucider le mécanisme de contrôle des NOS 
et les conséquences de la production d'oxyde nitrique pour le fonctionnement des 
cellules de la granulosa au cours du développement folliculaire chez la vache et (2) 
déterminer la régulation des NOS pendant la cascade ovulatoire induite par LH chez les 
cellules de la granulosa bovine et si l'activité des NOS pour l’expression des gènes 
critiques dans la cascade ovulatoire chez cette espèce. Les résultats sont séparés en 2 
articles. Dans le premier article, la régulation de NOS2 dans les cellules de la granulosa 
bovine a été explorée. L'abondance des ARNm codant pour NOS2 a été stimulée par la 
FSH et l’IGF1 en augmentant l’estradiol, et un blocage de l'action de l’estradiol a 
conséquemment réduit les niveaux d'ARNm codant pour NOS2. De plus, l'inhibition de 
l'activité des NOS a augmenté l'apoptose dans les cellules de la granulosa in vitro. Dans 
le second article, il a été démontré que le pic de LH induit une activation des NOS dans 
les cellules de la granulosa, et que l'activité de NOS induit la production de NO, ce qui 
est essentiel pour l’expression des gènes critiques dans la cascade ovulatoire induite par 
LH comme EREG/AREG/PTGS2. Ensemble, les résultats présentés dans ces 2 articles 
suggèrent que les niveaux physiologiques d'activité des NOS peuvent contribuer à la 
croissance et la survie des cellules de la granulosa et indiquent également que NO peut 
être essentiel pour l'ovulation chez les bovins.   
Mots-clés: oxyde nitrique, NOS, ovaire, follicule, cellules de la granulosa, apoptose, 
ovulation, vache 
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Abstract 
Understanding the paracrine events that regulate fertility in the cow is necessary not 
only because of the agricultural importance of this species, but also its potential use as a 
model for humans. Nitric oxide (NO), a free-radical gas, has been implicated in 
follicular growth and ovulation in rodents and other species, but the cow is an intriguing 
enigma: NO is produced by bovine granulosa cells and is regulated by FSH, but the 
presence and the expression pattern in granulosa cells of the enzymes responsible for 
NO synthesis (NOS) throughout follicular growth are unclear. The objectives of the 
present thesis were (1) to elucidate the mechanism of control of NOS and the 
consequences of nitric oxide production for granulosa cell function during follicle 
development in cattle; and (2) to determine the regulation of NOS during the LH-
induced ovulatory cascade in bovine granulosa cells and whether NOS activity is critical 
for the ovulatory cascade in this species. The results are separated in 2 articles. In the 
first article, the regulation of NOS2 in bovine granulosa cells was explored. Abundance 
of mRNA encoding NOS2 was stimulated by FSH and IGF1 through increased 
estradiol, and a blockade of estradiol action consequently lowered NOS2 mRNA levels. 
Further, inhibition of NOS activity increased apoptosis in granulosa cells in vitro. In the 
second article, it was demonstrated that the LH surge induces NOS activation in 
granulosa cells, and that NOS activity induces the production of NO, which is essential 
for EREG/AREG/PTGS2 expression, critical genes in the LH-induced ovulatory 
cascade. Together, the results presented in these 2 articles suggest that physiological 
levels of NOS activity may contribute to growth and survival of granulosa cells, and 
also indicate that NO may be essential for ovulation in cattle. 
Key words: nitric oxide, NOS, ovary, follicle, granulosa cells, apoptosis, ovulation, cow 
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Introduction 
 
 Ovarian follicles are the functional units of the ovary. Each follicle contains 
normally one oocyte, the female reproductive germ cell. The other cells that surround 
the oocyte to compose a mature ovarian follicle are somatic cells, and include cumulus 
and mural granulosa cells, and the cells of the theca layer [1]. The formation, 
development and maturation of an oocyte is defined as oogenesis, while the process that 
involves the proliferation and differentiation of somatic cells, and consequently, the 
maturation of the whole ovarian follicle is refered to as folliculogenesis. Both oogenesis 
and folliculogenesis are linked in an intimate and mutually dependent relationship [2, 3].   
 During the course of folliculogenesis, oocytes first acquire meiotic competence 
and then gradually acquire developmental competence, a biochemical and molecular 
state that allows a mature oocyte to undergo normal fertilization, support normal 
preimplantation embryo development and subsequent healthy growth of the implanted 
embryo to term. The support for the acquisition of oocyte competence is maybe the most 
important function of the follicle, with granulosa cells exerting an essential role [4, 5]. 
For this reason, it is crucial that granulosa cells are healthy and working properly. To 
guarantee the good functioning of granulosa cells, many endocrine factors such as 
gonadotropins, paracrine growth factors and intracrine modifiers of cell function 
modulate their development and function. Some, such as FSH and LH, have well 
defined roles in granulosa cells function, but the roles of others are less well defined. 
This is the case for nitric oxide (NO), a short-lived gas produced by the action of the 
enzyme nitric oxide synthase (NOS). This free-radical is produced in the ovary and has 
been implicated in different ovarian processes of several species. Although many studies 
have determined that NO modulates processes like steroidogenesis, follicular growth, 
oocyte maturation and ovulation [6-8], many questions about the regulation of the NO 
generation system as well the physiological effects of NO in granulosa cells still need to 
be answered. 
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 This thesis contains results from studies using cell models carefully selected to 
represent granulosa cells at different stages of development in cattle. The regulation of 
NOS mRNA levels in granulosa cells by natural ligands, including gonadotropins, 
steroids and growth factors in conditions that mimic follicle growth and differentiation, 
as well in conditions that simulate the periovulatory period, have been determined. The 
roles exerted by NO on granulosa cells during these two distinct physiological moments 
have also been described. These findings may provide new and clinically relevant 
information on the physiological role of a highly potent free radical gas in the ovary. 
The data obtained will advance significantly our understanding of follicle development 
and ovulation and should lead to better clinical approaches to infertility. 
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1. Ovarian follicular development and growth  
 Follicular development and growth can be driven by different regulators and 
involve complex interactions between the three main cell types within the follicle: theca 
cells, granulosa cells and the oocyte. The systemic endocrine regulation of 
folliculogenesis is related not only to the pituitary gonadotropins FSH and LH, but 
various locally produced hormones and growth factors. The oocyte has been confirmed 
as a major regulator of preantral and early antral follicular growth. On the other hand, 
late steps of antral follicle development and growth involve gonadotropins and growth 
factors, specially the insulin-like growth factor (IGF) system [3, 9]. 
 The following sections will focus mainly on basic aspects of ovarian follicular 
development and growth in cattle.  
 
1.1 Ovarian follicles  
 In ruminants, ovarian follicular formation is completed during fetal life. In cattle, 
follicular growth is initiated before the last primordial follicles are formed and then 
continues throughout fetal, neonatal and adult life [10]. Ovarian follicles can be 
classified as primordial, primary, secondary and tertiary or antral follicles (Figure 1). 
Some authors divide antral follicles in early or small antral follicles and late or large 
antral follicles. They not only present differences in their morphology, but also in their 
responsiveness to different regulators [3, 11]. 
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Figure 1. Ovarian follicle classification (http://www.bme.umich.edu/labs/shikanov/).                
 
 
1.1.1 Primordial follicles 
 In cattle, after day 90 of fetal life, the first follicles separate themselves by 
producing a basement membrane, forming the primordial follicles which are the largest 
population of follicles in the ovary. Each primordial follicle contains a small non-
growing oocyte and a layer of non-dividing flattened pre-granulosa cells encapsulated 
by the follicular basal lamina. The ovary has a reservoir of primordial follicles that is 
depleted as follicles gradually and regularly leave this resting pool and initiate growth 
[11]. In these follicles, the oocyte and granulosa cells have receptors for some growth 
factors, but not LH or FSH. The primordial follicles, however, do not require 
gonadotropins for their survival and continued development [12]. Many of the proteins 
expressed in primordial follicles are associated with cell maintenance and preparation 
for growth. A primordial follicle expresses hundreds of genes that fulfill housekeeping 
and signalling functions, cytoskeletal events, DNA repair, mRNA processing, ribosomal 
function, protein synthesis and ubiquitination. The delay between the appearance of the 
first primordial and the first primary follicles is relatively long, at 50 days in cattle [13, 
14].  
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1.1.2 Primary follicles 
 The first activated primary follicles do not appear in bovine fetal ovaries until 
Day 140 of pregnancy. Once follicles have left the pool of primordial follicles they 
undergo gonadotropin-independent growth, meaning that FSH and LH are not essential 
for their growth. These small pre-antral follicles present continuous growth that is 
mainly controlled by factors secreted by the oocyte [12]. The transformation of the 
flattened pre-granulosa cells of the primordial follicle into a single layer of cuboidal 
granulosa cell marks the transition to primary follicle [13]. As a follicle grows to the 
primary stage, the granulosa cells not only change shape but also divide and increase in 
number and the oocyte enlarges. The primary follicle is also characterized by the 
development of the zona pellucida (ZP), that was absent in primordial follicles. Several 
hundred genes not found in primordial follicles are activated during this stage of growth, 
including those related with synthesis of the ZP, as well some involved in mitochondrial 
function, cell signalling and communication [11].  
 
1.1.3 Secondary follicles  
 The secondary follicles are a group of large preantral follicles. They gain 
multiple layers of granulosa cells, from two to six layers around the oocyte. They also 
present a well delimited zona pellucida and a theca interna. The secondary follicles are 
considered gonadotropin-responsive because these follicles present not only FSH-
responsive granulosa cells but are also characterized by the development of LH-
responsive theca interna. The acquisition of the enzymes required for thecal androgen 
production is essentially complete before antrum formation [14, 15]. 
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1.1.4 Antral follicle formation 
 The antrum is a fluid-filled cavity that is formed in the follicles under the 
influence of FSH. A follicle with an antrum is named tertiary or antral follicle (Figure 
2). As antral follicles form, the granulosa cells differentiate into two anatomically and 
functionally distinct lineages; the mural granulosa cells that line the wall of the follicle 
and that have principally a steroidogenic role; and the cumulus cells, that form an 
intimate life-support association with the oocyte [16, 17].  
 
 Figure 2. Antral follicle structure (http://www.studyblue.com/notes/note/n/week-7-
female-reproductive-system-parysek/deck/5613015). 
 
 As follicle development progresses, follicles gradually become more and more 
reliant on gonadotropins, first as gonadotropin-responsive follicles and then as 
gonadotropin-dependent follicles [3].  
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Follicular growth is highly related to the secretion of steroids, especially estrogens. They 
are necessary for granulosa cell proliferation, growth of the oocyte and acquisition of 
LH receptors [18, 19]. 
 
1.2. Follicle steroidogenesis  
One of the most important functions of the follicle is the production of steroids. 
Follicular steroidogenesis in ruminants, as in other species, starts usually with 
cholesterol and ends with the formation of several steroid metabolites [20]. This 
involves both theca and granulosa cells (Figure 3). Basically, cholesterol is imported 
into the cell through internalization of blood-borne lipoproteins. Within the cell, 
cholesterol is maintained within lipid droplets as cholesterol esters. The enzyme 
cholesterol ester hydrolase converts the cholesterol esters to free cholesterol. Within the 
cytoplasm the free cholesterol is mobilized to the mitochondria, and then internalized. 
This internalization of cholesterol by the mitochondria is the rate-limiting step for the 
general steroidogenic pathway, and is mediated by steroidogenic acute regulatory 
protein (StAR). Once inside the mitochondria, cholesterol is converted to pregnenolone 
by the enzyme cytochrome P450 cholesterol side-chain cleavage (CYP11A1 or 
P450scc). Pregnenolone can then be converted to progesterone by the enzyme 3β-
hydroxysteroid dehydrogenase (3β-HSD or HSD3B2), or to 17α-hydroxypregnenolone 
by the enzyme cytochrome P450 17α- hydroxylase (CYP17 or P45017-OH). In ruminant 
luteal and granulosa cells, the enzyme CYP17 is not expressed, and so steroidogenesis 
goes through to progesterone; this progesterone is not metabolised further, and is 
secreted. In theca cells, however, there is abundant CYP17 activity, and so pregnenolone 
is converted to 17α-hydroxypregnenolone. This 17α-hydroxypregnenolone then 
undergoes sequential conversion to androstenedione by CYP17 and 3β-HSD activities. 
Ruminant theca cells convert limited amounts of androstenedione to testosterone with 
the enzyme 17β-hydroxysteroid dehydrogenase (17β-HSD or HSD17B1), and both 
androstenedione and testosterone are secreted. A good portion of these secreted 
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androgens are absorbed by the neighbouring granulosa cells and are further converted to 
estrogens. Ruminant granulosa cells prefer to metabolize androstenedione to estrone by 
the enzyme cytochrome P450 aromatase (CYP19A1), and then the estrone is 
metabolized to estradiol by 17β-HSD. Alternatively, testosterone can be metabolised to 
estradiol by CYP19A1 [21, 22].  
 
 
Figure 3. Major steroidogenic pathways in the follicle (Taken from [22]). 
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1.2.1 Roles of gonadotropins and insulin-like growth factor-1 (IGF1) in steroidogenesis  
The production of both estradiol and progesterone is regulated within the follicle 
throughout  follicle growth. Summarizing the steroidogenic pathway described above, in 
ruminants, granulosa cells convert theca-derived androgens to estrogens with the 
enzyme CYP19A1 and may convert androstenedione to testosterone and/or estrone to 
estradiol with 17β-HSD. These and other steroidogenic enzymes are under the 
regulation of gonadotropins and growth factors.  
Theca and luteal cells express LH receptors and the steroidogenic enzymes 
present in these cells are normally up-regulated by LH. Consequently, LH induces 
androgen secretion from theca cells and stimulates progesterone secretion from luteal 
cells.  In granulosa cells of smaller follicles, the only gonadatropin receptor expressed is 
FSHR; and FSH regulates both estradiol and progesterone secretion. In cattle as well as 
other species, FSH acts mainly through a cAMP pathway and can be considered one of 
the primary stimulators of granulosa CYP19A1 expression, but also regulates the 
expression of CYP11A1 [23, 24]. In larger follicles, LHR is also expressed in granulosa 
cells and LH modulates mainly progesterone secretion [25, 26].  
A number of growth factors have also been shown to alter steroid production. A 
growth factor critical to follicular growth is IGF1. It stimulates estradiol and 
progesterone secretion in bovine follicles. IGF1 acts through PI3K and PKC pathways 
to increase expression of CYP19A1 [24, 27] and other steroidogenic enzymes in bovine 
granulosa cells and to stimulate progesterone and androstenedione secretion in theca 
cells [28-30].  
 
1.3 Follicular dynamics in the cow  
The cow, like women and mares, is a mono-ovulatory species, and generally 
ovulates one follicle per cycle. As a non seasonal polyestrus species, the cow 
continually has estrous cycles all year around. The entire estrous cycle averages 21 days  
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and studies using ultrasonic imaging to monitor follicle populations in different size 
categories or to monitor individually identified follicles have convincingly documented 
that follicular growth occurs in a wave-like fashion and that the majority of estrous 
cycles in cattle are comprised of two or three such waves. Two-wave cycles are 
consistently shorter (19–21 days) than three wave cycles (22–23 days) [31, 32]. 
In gonadotropin-responsive and gonadotropin-dependent follicles, inadequate 
support from gonadotropins leads to their regression. It is the developing dependence on 
gonadotropins that transforms folliculogenesis from a linear process in the preantral and 
early antral stages of development into a wave-like process during the terminal stages of 
folliculogenesis, as gonadotropin-dependent follicles grow and regress in a regular 
sequential pattern of waves [3].  
 
1.3.1 Follicle wave emergence  
 During the antral growth stage, the most advanced follicles in the pool of 
gonadotropin-responsive follicles are those that emerge concomitantly with the 
increases in FSH to form what is commonly referred to as the cohort of gonadotropin-
dependent follicles. In a more classic concept, follicular wave emergence is defined as 
the sudden growth of a group of small follicles that are initially detected by 
ultrasonography at a diameter of 3–5 mm. In cattle, in both two- and three-wave estrous 
cycles, the emergence of the first follicular wave occurs consistently on the day of 
ovulation [33]. Until recently, reference to a follicular wave in cattle was limited to 
follicles larger than 4 mm, based simply on the limit of resolution of existing ultrasound 
equipment. The accessibility to new ultrasound scanners capable of resolving structures 
as small as 1 mm permitted some authors to determine that, 1 or 2 days before 
conventionally defined wave emergence, 1–3 mm follicles have already developed in a 
wave-like manner in association with a FSH surge in plasma. During this phase, the 
follicles grow at an approximately similar rate and each follicle has the capacity for 
future dominance and no follicle exerts dominance over its cohort [34, 35].  
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1.3.2 Follicle selection and diameter deviation 
 The follicles emerging in the same wave present a similar growth rate for 
approximately 2 days, after which one follicle is selected for further growth. In cattle, as 
in other monovular species, this process is known as follicle selection [36, 37]. Selection 
of the dominant follicle is associated with decreasing blood FSH concentrations during 
the first 3 days of the wave. The nadir in FSH is reached 4 days after wave emergence, 
and concentrations remain low for the next 2–3 days. One of the reasons by which the 
selected follicle may continue its growth is related to the IGF system. IGF1 increases the 
sensitivity of small follicles (around 5 mm in cattle) to gonadotropins and simulates 
their transition from the gonadotropin-responsive to the gonadotropin-dependent stages 
[38]. 
 The moment when the selected follicle continues its growth, while the remaining 
follicles cease growing, is known as diameter deviation [39]. At the beginning of 
deviation, the largest follicle in cattle is about 8.5 mm and second largest follicle is 
about 7.2 mm [40]. Although there is no significant difference in size, intrafollicular 
biochemical events ensure future dominance of the selected follicle. The intrafollicular 
factors responsible for these biochemical changes include those related to the IGF 
system, steroids, inhibin-A/activin-A peptides, gonadotropin receptors and angiogenic 
factors [40-42] . However, IGF1 and its associated system, estradiol secretion and the 
presence of LH receptors have been temporally and/or functionally well implicated with 
follicle deviation and may be useful markers. In cattle, it was shown that the 
concentrations of free IGF1 remains constant or increase in the largest follicle before the 
equivalent period at the beginning of deviation [43], which is also marked by an 
increase in estradiol levels. IGF1 not only induces estradiol secretion in granulosa cells, 
but also stimulates granulosa cell proliferation and synergizes with gonadotropins to 
promote differentiation of granulosa cells [29, 44]. All these data support the concept 
that the IGF-system via IGF1 is an initiator of the beginning of follicle deviation and 
therefore a good marker for selection. 
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1.3.3 Follicle dominance  
 Follicle dominance is defined as the emergence of one follicle as significantly 
larger than the rest of the cohort, and that is morphologically a functionally dominant 
[9]. Probably the most important characteristic of the dominant follicle is its greater 
capacity for estradiol production. After the wave emergence, estradiol content in the 
follicular fluid of the growing dominant follicle increases at least 20-fold by the day of 
selection [35, 37]. In cattle, follicular-fluid concentrations of estradiol begin to increase 
differentially in the largest versus second largest shortly before or at the expected 
beginning of deviation. This dominant follicle secretes sufficient estradiol and inhibin to 
suppress FSH, which as a consequence, promotes atresia in the remaining gonadotropin-
dependent follicles and preventing the emergence of a new cohort of gonadotropin-
responsive follicles [39, 45, 46]. 
The increased estradiol secretory capacity of the dominant follicle is because it 
is molecularly distinct from the others even before the beginning of deviation. Estradiol 
synthesis is dependent upon gonadotropic stimulation of both androgen synthesis in 
theca cells and its aromatization to estradiol in granulosa cells. In cattle, the selected 
follicle presents higher expression of the gene for CYP19A1 near the beginning of 
deviation. Levels of mRNA for CYP17 in theca cells and for CYP19A1 in granulosa 
cells are higher in early dominant follicles than in recruited follicles, whereas mRNA for 
CYP11A1 is higher in granulosa, but not theca cells [47-49]. This explains the increased 
potential for estradiol production by the selected dominant follicle in comparison to the 
subordinate follicles. 
Studies performed to determine changes that occur in granulosa cells when the 
most successful follicle of the cohort becomes dominant show that the majority of the 
transcripts up-regulated in granulosa cells of the dominant follicle are encoded by genes 
that regulate not only estradiol synthesis, but also cell proliferation and survival, 
signalling, organ development and extracellular tissue remodelling [50, 51]. 
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1.3.4 Ovulatory follicles 
 In cattle, about three days after emergence, one or a few follicles achieve 
potentially ovulatory status. The dominant follicle shifts its gonadotropin dependence 
from FSH to LH during the FSH nadir, and is able to continue to grow while the 
subordinates regress. In bovine, LH receptor (LHR) mRNA in granulosa cells is 
detected in follicles greater than 8 mm, but not in follicles smaller than 8.0 mm or in 
subordinate follicles [26, 52]. 
           The ovulation occurs, however, if the preovulatory follicle grows in the correct 
endocrine milieu that involves appropriate progesterone and estradiol levels and LH 
pulse frequency (Figure 4). Pulse frequency and amplitude of LH are influenced by 
circulating concentrations of both progesterone and estradiol. High levels of 
progesterone produced by a functional corpus luteum (CL) during diestrus or pregnancy 
suppress LH pulse frequency. The non-ovulatory wave is marked by the presence of a 
CL, and consequently, high levels of progesterone. In these conditions LH pulse 
frequency is suppressed and the gonadotropin-dependent dominant follicle undergoes 
atresia, secreting less estradiol and inhibin so that FSH concentration can increase and 
start a new wave [36, 53]. On the other hand, the dominant follicle present at the onset 
of luteolysis becomes the ovulatory follicle. The plasma progesterone concentrations 
decrease and the LH pulse frequency increases, permitting the dominant follicle grow 
larger and remain dominant. Increasing estradiol concentrations with decreasing 
progesterone after luteolysis increase LH pulse frequency, culminating in a large 
prevulatory LH surge and ovulation [54]. 
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Figure 4. Ovarian follicular dynamics during the estrous cycle. Schematic of the pattern 
of secretion of FSH (blue line), LH (green lines), and P4 (orange line); and the pattern of 
growth of ovarian follicles during the estrous cycle in cattle (Taken from [55]). 
  
 1.4 Follicle atresia  
The bovine ovary contains hundreds of thousands of follicles at birth, but very 
few follicles successfully ovulate and more than 99.9% undergo atresia, the process of 
degeneration of ovarian follicles. Atresia happens at various stages of follicular 
development [56], but the collective evidence suggests that the rate of follicular atresia 
is very low during the preantral stages of growth while the transition to an antral follicle 
is accompanied by a significant increase in the rate of atresia, indicating that it is a 
physiological challenge for the follicle to form an antrum and to maintain the granulosa–
oocyte syncytium. It has been estimated that the incidence of atresia in bovine follicles 
is greatest after antrum formation, just before the final stages of follicular development 
[3, 57].  
 Both subordinate and dominant follicles may stop their growth and regress 
through the atretic process under different circumstances. General morphological signs 
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of atresia include decrease of follicle wall thickness characterized by the reduction of 
granulosa cells layer thickness, which becomes loose and disorganized. An advanced 
stage of atresia is characterized by follicle cell degeneration, initially in the granulosa 
cell layer. The death of granulosa cells leads to almost total destruction of the granulosa 
cells layer lining the inner follicular wall with the consequent destruction of follicular 
structure [57, 58]. All these morphological changes in an atretic follicle are preceded 
and/or accompanied by molecular and biochemical changes that include a marked 
decrease in concentrations of estradiol in follicular fluid and reduced expression of 
mRNA encoding FSHR, several steroidogenic enzymes and many survival genes [48, 
59, 60]. 
 
1.4.1 Apoptosis in ovarian follicles  
 Apoptosis is a process of cell self-destruction and is an event associated with the 
initiation and progression of ovarian follicular atresia in all vertebrate species  [56, 61]. 
Cell death is mediated through caspase activity. Caspases are cysteine proteases that 
cleave their substrate proteins specifically at an aspartate residue. They are 
constitutively expressed in an inactive proenzyme form and are activated after cleavage 
at specific aspartate residues. The activation of execution caspases, such as caspase-3, 8 
and 9, indicates the point of no return in the apoptotic pathway. These proteins either 
directly or indirectly cleave a broad array of proteins necessary for cell survival, such as 
those involved in DNA maintenance and repair and organization of intermediate 
filaments. During the apoptosis, the nucleus breaks into several fragments, then the cell 
breaks up into several membrane bound smooth-surfaced apoptotic bodies [58]. 
 Apoptosis of granulosa cells is an early feature of atresia in bovine follicles [58, 
62, 63]. A number of mechanisms have been proposed to induce apoptosis and 
activation of caspases in granulosa cells. These include binding of specific ligands to 
their respective receptors, such as tumor necrosis factor-alpha [61], inhibition of cell–
cell contact [64], presence or absence of specific growth factors [65], and altered levels 
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of hormones such as estrogens and androgens [66]. Some studies demonstrate that a 
high concentration of progesterone may play an important role in initiating the 
regression of non-ovulatory dominant follicles during the bovine estrous cycle [58]. In 
addition,  follicular apoptosis may be induced by oxidative stress [67]. 
 A particular and interesting trigger for apoptosis in granulosa cells is Fas antigen 
[68]. Fas is a cell surface receptor that induces apoptosis when bound by Fas ligand 
(FasL). The Fas system has been shown to mediate bovine granulosa cell apoptosis. In 
this species, granulosa and theca cells are susceptible to FasL-induced apoptosis to 
varying degrees. The expression of Fas mRNA and responsiveness of granulosa cells to 
FasL-induced apoptosis is higher in atretic subordinate follicles compared with healthy 
dominant follicles [65, 69]. The fact that both mRNA and protein for Fas and its ligand 
are high in follicles undergoing atresia, indicate that the Fas pathway is involved in the 
initiation and/or progression of apoptosis [69, 70]. Activation of the Fas pathway leads 
to cleavage and activation of caspases. Furthermore, cell death is inhibited by reagents 
that prevent binding of FasL to Fas, providing evidence that apoptosis is mediated, at 
least partially, by binding of endogenous Fas and FasL on granulosa cells [71]. 
 
1.4.2 Anti-apoptotic mechanisms in granulosa cells  
 Follicle cells are thought to initiate apoptosis in the presence of cytotoxic signals 
or in the absence of necessary survival signals [61]. Gonadotropins and growth factors 
have been reported to play critical roles in preventing apoptosis in granulosa cells of 
antral follicles [72]. The process of apoptosis in follicles is associated with decreased 
levels of FSHR and LHR mRNAs, and consequently, a consistent decreased response of 
granulosa cells to gonadotropins [59]. FSH binding to its receptor promotes ovarian 
follicle survival and growth not only by stimulating proliferation, but also inhibiting 
apoptosis by up-regulating the expression of intracellular anti-apoptotic proteins such as 
X-linked inhibitor of apoptosis protein [73, 74]. IGF1 also stimulates bovine granulosa 
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cell proliferation and survival [75]. In addition, IGF1 inhibits FasL-induced apoptosis of 
bovine granulosa cells [65].  
 The effects of FSH and IGF1 on follicle cell survival, however, are also related 
to their ability to stimulate estrogen synthesis. During follicular development, both FSH 
and IGF1 stimulate estrogen production in vivo and in vitro. Some studies have 
implicated estrogen as an inhibitor of apoptosis [66]. In cattle, follicles that are selected 
for continued growth and development to the ovulatory stage have increased capacity to 
secrete estradiol relative to follicles destined to undergo atresia [36]. The occurrence of 
apoptosis in individual atretic follicles is correlated with decreased levels of CYP19A1 
mRNA and intrafollicular estrogen levels. One of the mechanisms used by estradiol to 
protect bovine granulosa cells from FasL-induced apoptosis in vitro is related to its 
effect on progression through the cell cycle [19]. 
 
2. Ovulation  
 Ovulation is the rupture of the follicle wall and release of the oocyte-cumulus 
complex. The ovulatory process depends on a coordinated activity of gonadotrophins, 
steroid hormones and mediators involved in an inflammatory reaction, such as 
prostaglandins. Some of the most significant changes that occur during the periovulatory 
period include meiotic maturation of the oocyte, follicular rupture and ovulation; and the 
shift in follicular steroidogenesis from androgen/estradiol to progesterone as the primary 
steroid product secreted by granulosa cells [76]. 
 The following section will describe briefly the main aspects related to the 
preovulatory cascade in the cow and also in other species, especially rodents due to the 
large body of literature in mice and rats. 
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2.1 The preovulatory cascade    
 The main trigger of the preovulatory cascade is LH, which activates a cascade of 
signaling events that are propagated throughout the ovarian preovulatory follicle to 
promote ovulation of a mature egg. Although LH directly stimulates theca and granulosa 
cells, its effects on cumulus cells and oocytes are probably indirect, as both cell types 
express few or no LH receptors and fail to respond when directly stimulated by LH [77]. 
In minutes to hours post-LH, several genes are rapidly and transiently up-regulated, 
causing the required physiological and phenotypic changes in the follicular cells that 
culminate in ovulation and luteinization.  
 
2.1.1 LH signaling pathways activation 
 LH activates a number of cellular signaling cascades within the preovulatory 
granulosa cell. The LHR, a classical G-protein-coupled receptor (GPCR), activates 
adenylate cyclase, resulting in a large intracellular cAMP increase that activates the 
cAMP-dependent serine kinase protein kinase A (PKA) [78]. Although LH rapidly 
induces in a PKA-dependent manner the expression of several genes in the preovulatory 
follicle, other important pathways are activated by LH for the induction of essential 
genes for ovulation (Figure 5), including extracellular regulated kinase (ERK1/2 or 
MAPK3/1), phosphoinositide 3-kinase/AKT (PI3K/AKT) and mitogen-activated protein 
kinase 14 (MAPK14 or p38) signaling pathways [77, 79, 80].  
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Figure 5. Important signaling cascades in ovulation (Modified from illustration on 
[81]).  
 
 Studies with porcine cumulus cells demonstrated that inhibition of MAPK14 or 
PKA activity resulted in significant inhibition of MAPK3/1 phosphorylation [82], 
suggesting that these pathways may converge on MAPK3/1. Moreover, mice in which 
ERK1 and ERK2 have been disrupted in granulosa cells exhibit normal follicle growth, 
but in response to LH, the COCs fail to expand, oocytes fail to re-enter meiosis, and 
follicles fail to either ovulate or luteinize [83]. The ERK1/2 pathway seems to be 
essential to LH effects during the preovulatory period. 
 
2.1.2 ADAMs  
 ADAMs are type I transmembrane proteins with both metalloproteinase and 
disintegrin domains [84]. ADAMs are implicated in cell–cell and cell–matrix 
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interactions and shedding of membrane-bound precursors such as EGF family ligands 
[85, 86]. In terms of the preovulatory cascade, LH induces ADAMs expression/activity 
which in turn cleave and release the pre-formed EGF-like growth factors from the 
surface of mural granulosa cells [87, 88]. Increased expression of EGF family ligands 
accompanies the cascade of events resembling an inflammatory and/or tissue 
remodeling process during the preovulatory period, and shedding and action of such 
autocrine and paracrine signals is critical for LH actions [79, 89, 90]. 
  
2.1.3. EGF-like growth factors   
 The EGF-like factors include amphiregulin (AREG), epiregulin (EREG) and 
betacellulin (BTC). These factors were identified as genes rapidly induced by LH in 
granulosa cells and by EGF in cumulus cells as illustrated in the previous figures above 
[91]. Studies with mice in vivo demonstrate that AREG and EREG mRNA levels are 
increased within 1 h after hCG injection [87, 92-94]. In cattle, a recent in vitro study 
indicates that LH increased EREG mRNA levels within 1 h but did not alter AREG 
mRNA levels in mural granulosa cells until 6 h after challenge [95]. Once released, 
AREG/EREG then act in a paracrine manner to stimulate the EGF receptor of cumulus 
cells [89, 96]. EGF receptor activation results in AREG/EREG expression in the 
cumulus and increased prostaglandin-endoperoxide synthase 2 (PTGS2) expression. 
This same loop occurs in mural granulosa cells with EREG/AREG acting in autocrine 
manner to intensify the cascade [95].  
 Disruption of the EGF ligand/receptor signaling pathway in mice compromises 
ovulation, indicating that activation of this pathway is essential for LH-induced 
ovulation to occur [97]. The EGF-like factors bind their cognate receptors present on 
granulosa cells and cumulus cells, activate RAS, a small GTPase involved in 
transmitting signals, and induce expression of downstream target genes, including not 
only PTGS2 but also hyaluronan synthase 2, TNF-α– induced protein 6 and several 
other genes, each of which is a target of ERK1/2 in cultured cells [90, 98]. Thus, 
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ERK1/2 controls a master switch that mediates the global reprogramming of granulosa 
cells downstream of EGF-like–factor activation of the EGF receptor pathway. Several 
transcriptional regulators are known to affect ovulation and appear to help mediate the 
effects initiated by ERK1/2 (Figure 6). 
 
 
 Figure 6. LH-induced RAS/ERK1/2 signaling pathway. Activation of ERK1/2 is 
essential to turn off the FSH regulated gene expression program that controls genes 
essential for preovulatory follicle growth and differentiation. Key transcription factors 
that are activated by ERK1/2 phosphorylation and affect ovulation and luteinisation 
(Taken from [90]). 
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2.1.4. Prostaglandins  
 A key element in the cascade that culminates in the rupture of the follicle wall is 
the synthesis of prostaglandins (PGs) by granulosa cells. Prostaglandins are produced 
from arachidonic acid by a LH-inducible enzyme, prostaglandin-endoperoxide synthase 
2 (PTGS2; [99, 100]. In cattle, concentrations of prostaglandin E2 (PGE2) and 
prostaglandin F2alpha (PGF2α) in the follicular fluid remain low until late in the 
periovulatory period, increasing dramatically in the hours preceding ovulation [101]. In 
addition, studies in vitro using bovine granulosa cells collected from preovulatory 
follicles and challenged with LH show that PTGS2 mRNA levels significantly increase 
by 6 hours [95] or later [101]. In vivo studies with this species indicate that PTGS2 
mRNA abundance increases around 12 hours post-hCG/GnRH challenge and suggest 
that PGs secretion do not commence until late in the periovulatory period, between 18 
and 24 h after GnRH [102-104]. 
   The essential participation of PGs to the ovulation has been demonstrated in 
different studies. PTGS2-null mice failed to ovulate [105] and the use of a broad-
spectrum prostaglandin inhibitor (indomethacin) blocked ovulation in mice, rats, rabbits, 
sheep, pigs and primates [77]. In cattle, the intrafollicular injection of indomethacin 
[106] or a PTGS2-selective inhibitor also inhibited ovulation [107]. PGs promote a 
highly localized inflammatory response in the follicle prior to ovulation and act, at least 
in part, by stimulating the expression of proteases, including plasminogen activators, in 
the follicle wall to promote follicular rupture [108]. Prostaglandins have been also 
involved in a wide array of ovulatory and luteal events, including cumulus expansion, 
oocyte maturation, angiogenesis and progesterone production [109, 110]. 
 
2.1.5 Cumulus expansion and oocyte maturation   
 As a consequence of the ovulatory surge of LH, cumulus cells respond with a 
specific pattern of gene induction that leads the cumulus cells to produce a hyaluronan-
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rich matrix that surrounds the oocyte prior to ovulation. This process, known as cumulus 
expansion or mucification, depends on a specific cascade of intracellular signals and 
extracellular matrix gene expression within the cumuls-oocyte complex (COC), and 
exerts a key role in the ovulatory process [111-113]. The set of genes expressed in 
periovulatory cumulus cells are critical for normal rates of ovulation and fertility. 
Studies of knockout mice demonstrated that EREG-null mice and PTGS2-null mice both 
exhibit defective cumulus expansion, reduced ovulation rate and infertility [97, 105]. 
Genes encoding COC matrix components are also induced in cumulus cells by FSH or 
EGF in conjunction with oocyte signals, including HAS-2, TSG-6 and pentraxin-3 [112-
115]. 
 Cumulus cell expansion and resumption of meiosis with germinal vesicle 
breakdown (GVBD) are major events in oocyte maturation. In mammalian follicles, 
primary oocytes enter meiosis but are arrested at the diplotene stage of prophase I. The 
oocytes stay in this dormant state for months and years until the preovulatory stage. In 
response to the preovulatory LH surge, the germinal vesicle of the oocytes in 
preovulatory follicles undergoes GVBD, which is then followed by chromatin 
condensation and the formation of meiotic spindles while the oocyte progresses through 
the maturation process. The transition from metaphase I (MI) to metaphase II (MII) is 
accompanied by extrusion of the first polar body. The maturing oocyte is the site of 
phosphorylation events that activate or deactivate the proteins involved in progression of 
the cell cycle [116]. Several kinases, including members of the mitogen-activated 
protein kinase (MAPK) family, are activated by a kinase pathway during this period 
[117]. 
 Signals produced by cumulus cells appear to influence oocyte maturation [17]. 
The PTGS2-derived PGs produced by cumulus cells appear to constitute critical 
mediators not only of cumulus expansion, as described above, but also for oocyte 
maturation. PGE2 is the main PTGS2-related prostaglandin produced by cumulus cells 
both in vivo and in vitro and acts directly on the oocyte to activate the proteins involved 
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in meiosis progression. [118-120]. PGE2 acts as a direct enhancer of oocyte MAPK 
activity during the maturation process [110].  
 
2.2. Follicule rupture 
 The follicle wall rupture that characterizes ovulation is one of the most important 
processes in  female reproduction. The ovulation can be considered similar to an 
inflammatory process that is characterized by vascular changes and proteolytic 
degradation of the follicle wall [121-123]. 
 As with all the other intrafollicular processes during the preovulatory period, 
follicle rupture is also linked to PGs action. In cattle, the inhibition of PGs synthesis by 
the intrafollicular administration of indomethacin blocks the LH surge-induced key 
mediators of extracellular matrix remodeling, consequently blocking ovulation [108]. 
PGE2 presents a key role in ovulation as a mediator of proteolytic degradation of the 
follicle wall. PGE2 alone or in combination with LH increased fibrinolytic activity in 
the medium of cultures of rat granulosa cells, whereas the PG synthesis inhibitor 
indomethacin blocked gonadotropin-induced fibrinolysis. Tissue-type PA (tPA) and 
urokinase-type PA (uPA) are serine proteases that convert plasminogen into the active 
proteolytic enzyme plasmin and studies demonstrate that PGs, especially PGE2, 
regulates PA-mediated proteolysis [124]. 
   
2.3 Corpus luteum  
 The LH surge causes ovulation and rapidly initiates a program of terminal 
differentiation of the ovulated follicle into a transient endocrine gland, the corpus 
luteum (CL) through a process termed luteinization. This essential process of luteal 
development is, as described previously, marked by the remodeling of extracellular 
matrix and by the differentiation and proliferation of cells derived from the 
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postovulatory follicle, such as granulosa, theca, and vascular endothelial cells [125]. In 
cattle, the CL rapidly develops within 2–3 days after ovulation, which is accompanied 
by active angiogenesis and vascularization from the preovulatory follicle [126].  
  
2.3.1. Corpus luteum functions 
 The most important function of the CL is the production of progesterone, which 
is required for achievement and maintenance of pregnancy. In cattle, after CL formation, 
plasma progesterone concentrations progressively increase. Plasma progesterone 
concentrations peak between 10 and 14 days post-ovulation. The CL also produces 
many vasoactive factors such as nitric oxide [126], endothelin-1 [127], angiotensin II 
[128] and PGF2α [129]. In the cow, these factors are involved in the regulation of CL 
blood flow and progesterone secretion. If pregnancy does not occur successfully in this 
species, the CL is only functional for 17–18 days and it will regress in a process called 
luteolysis [126, 130].  
  
2.3.2. Luteolysis 
 If there is no maternal recognition of pregnancy, PGF2α released from the 
endometrium of the nonpregnant cow induces luteolysis, characterized by hypoxic cell 
death resulting from hyalinization of blood vessels. In ruminants, it is well known that  
pulsatile PGF2α release from the uterus on days 17–18 of the estrous cycle is essential 
to induce regression of the CL [131]. Luteolytic PGF2α induces a drastic decrease in 
progesterone secretion from the CL as well as CL volume and blood flow  in the non-
pregnant cow [132, 133]. 
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3. Nitric oxide system 
 For many years, nitric oxide (NO) was considered an atmospheric pollutant, 
formed as a product of nitrogen burn from industrial and automobile exhaust fumes. By 
1987, it was confirmed that this labile molecule could be synthesized within cells of live 
organisms [134, 135]. In the following years many studies were published indicating 
that NO was a mediator of a variety of biological functions. In 1992, NO was named 
“Molecule of the Year” by Daniel E. Koshland, Editor for Science. In 1998, the 
researchers who discovered NO as a signal molecule in the cardiovascular system, 
Robert F. Furchgott, Louis J. Ignarro and Ferid Murad, were awarded with “The Nobel 
Prize in Physiology or Medicine” [136]. The signal transmission by a gas that could be 
produced with in a cell, penetrate through membranes and regulate the function of 
another cell, represented a new principle for signalling in biological systems. 
 
3.1. Nitric oxide biosynthesis 
 Within the cell, NO is generated as a co-product of the enzymatic reaction that 
converts the amino acid L-arginine into the amino acid L-citrulline. The enzymes 
responsible for this reaction are called nitric oxide synthase (NOS). The amount of NO 
produced by each cell type depends not only on which NOS is present, but also the 
intensity of its activity in response to different stimulis. The proper amount of substrates 
and co-factors are also critical for NO synthesis. Availability of L-arginine is essential 
for NO generation because it is known that L-arginine is the only physiological nitrogen 
donor for NOS-catalyzed reactions [137-140]. 
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3.1.1 Nitric oxide synthases  
 The different NOS enzymes are named according to the tissues from which the 
original cDNA and protein were isolated. The neuronal (nNOS) and endothelial (eNOS) 
enzymes, were first found in brain and vascular endothelial cells, respectively [141]. 
The inducible enzyme (iNOS) was first detected in macrophages, and expressed in 
response to inflammatory cytokines and lipopolysaccharides [137]. Some authors also 
consider a mitochondrial (mNOS) enzyme [142, 143], however, this is controversial and 
it is believed that the mNOS could be another NOS translocated to the mitochondria 
[144]. In this thesis, only information related to the neuronal, inducible and endothelial 
NOS will be reviewed. The current gene symbols for nNOS, iNOS and eNOS are 
NOS1, NOS2 and NOS3, respectively [145]. 
 Molecular cloning has shown that different bovine NOS share around 60% 
homology in this species [146]. The mammalian NOS proteins show a very high level of 
conservation [146]. The first NOS to be purified and cloned was the rat NOS1, which is 
constitutively expressed at high levels in the brain [147]. The bovine NOS1 gene located 
in the chromossome 17 and consists of 25 exons and 24 introns. The transcript presents 
a length of 3975 bps and a protein of 1325 residues (Ensembl: 
ENSBTAG00000002023). In cattle, NOS1 can be detected in heart, kidney, intestin, 
spleen, brain, liver, uterus and testis [148]. 
 The inducible NOS, NOS2, was first isolated from activated murine 
macrophages and characterized by a subunit of molecular mass of approximately 130-
135 kDa [149, 150]. As the name suggests, the NOS2 is not generally expressed in 
unstimulated cells, although exceptions to this rule of course exist. Bovine NOS2 shows 
a high degree of similarity to NOS2 from other species, and also shares a common 
protein domain structure. In  cattle, a 3471 bp transcript and a protein of 1156 amino 
acids have been identified [146]. The bovine NOS2 gene is located in chromosome 19 
and contains 26 exons and 25 introns (Ensembl: ENSBTAT00000009062.5). This 
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enzyme is induced in a wide range of cell types and tissues. In bovine tissues, NOS2 can 
be detected in heart, kidney, intestin, spleen, brain, liver, uterus and testis [148].  
  The endothelial NOS gene, NOS3, is highly conserved among  species [158] and 
is a membrane-bound protein of 135 kDa synthesized by endothelial cells and other cell 
types. In bovine tissues, NOS3 can be detected in heart, kidney, intestine, spleen, brain, 
liver, uterus and testis [148]. The NOS3 gene plus 2.9 kilobases of 5'-flanking sequence 
has been isolated and characterized in cattle. The gene (Ensembl: 
ENSBTAG00000017680) is located in chromosome 4 and spans 20 kilobases and 
contains 26 exons and 25 introns.  
 
3.1.1.1 Transcriptional regulation of NOS 
 Analysis of the bovine NOS2 promoter, sequenced from a Holstein animal 
(GenBank: AF333248), identified a TATA box 30 bp upstream of the bovine 
transcription start and binding sites for the several transcription factors [151], including 
AP-1, IRF-1, Ets-1 and NF-kB [152, 153]. Increased expression of NOS2 can be 
correlated with a number of pathological situations and several studies indicate that 
NOS2 expression can be induced by immunostimulatory cytokines, oxidative stress and 
bacterial products [154]. On the other hand, there are many reports that show expression 
of NOS2 during normal physiology in response to signals that are noninflammatory or 
nonimmunologic. The induction of NOS2 in cattle has been shown following 
stimulation of cells with viruses, bacteria, LPS and cytokines [155-157], but also 
induced by hormones and different factors. 
 The 5'-flanking region of NOS3 lacks a typical TATA box but contains 
numerous putative transcription factor binding sites. These include consensus sequences 
for an AP-1 site, an NF-1 site, a tumor necrosis factor responsive element, two sterol 
regulatory elements, 3 acute-phase response element, two sterol regulatory elements, 3 
acute-phase response elements, 6 GATA motifs, 16 CACCC boxes, 5 Sp1 sites, 15 
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estrogen half-palindromic motifs, and 9 fluid shear stress-responsive elements [158]. 
Although NOS3 is considered a constitutively expressed gene, it is known that NOS3 
may be transcriptionally regulated [159]. 
 
3.1.1.2 NOS protein structure 
  NOS proteins possess a bi-domain structure, consisting of two identical 
monomers, which are functionally divided into two major domains: a C-terminal 
reductase domain and an N-terminal oxygenase domain [160]. The reductase domain 
has binding sites for calmodulin, nicotinamide adenine dinucleotide phosphate reduced 
form (NADPH), flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). 
The oxygenase domain has binding sites for the cofactors heme and tetrahydrobiopterin 
(BH4 or H4B) and the substrate L-arginine [161, 162] (Figure 7). 
 
 
Figure 7. The general structure of the NOS enzymes                                  
(http://www.reading.ac.uk/nitricoxide/intro/no/synthesis.htm) 
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3.1.2 Enzymatic reaction 
 As mentioned previously, each NOS functions as a dimer consisting of two 
identical monomers. The heme is critical to the enzymatic reaction because it 
participates in dimerization, as NOS exists as monomers in its absence. Monomers of all 
the enzymes are unable to bind to BH4 or L-arginine [150, 163]. Each enzyme acts as a 
dimeric protein in catalysing the NADPH-dependant electron oxidation of L-arginine. 
Briefly, the reductase domain transfers electrons from NADPH along the flavins and 
calmodulin to the catalytic heme centre in the N-terminal portion of the protein [161].  
L-arginine is then hydroxylated by NOS to form N-hydroxy-L-arginine (NHA) as an 
intermediate, which is subsequently oxidized to yield L-citrulline in addition to NO 
(Figure 8), in a 1:1 stoichiometry [160]. 
 
  
 
Figure 8. Nitric oxide synthesis from L-arginine (Taken from [164]). 
 
3.1.3 NOS activation 
 An important molecule related to NOS activation is calcium. Increase in 
intracellular calcium triggers a cascade of events leading to NOS activation and NO 
synthesis. Intracellular calcium binds to calmodulin to form a calcium–calmodulin 
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complex and to regulate the binding of calmodulin to the ‘latch domain’, which permits 
electron transfer from NADPH via flavin groups within the reductase domain to a heme-
containing active site, thereby facilitating the conversion of oxygen and L-arginine to L-
citrulline and NO [165, 166].  
 The NOS1 and NOS3 enzymes are functionally similar and neither contain 
bound calmodulin. In the presence of calcium, however, when the high affinity 
association between calcium and calmodulin refered to above occurs, it results in the 
activation of the enzyme. For this reason NOS1 and NOS3 are commonly classified as 
calcium/calmodulin-dependent [162, 167], although NOS3 can also be activated in a 
calcium-independent manner [168]. These two NOS catalyse NO production within 
seconds in response to diverse stimuli and produce small quantities (at nM) of NO [150, 
169]. On the other hand, NOS2 contains calmodulin so tightly bound that it is 
considered to be a subunit rather than a cofactor [170]. This synthase has the shortest 
sequence and binds calmodulin at all physiological concentrations of calcium and unlike 
the other two enzymes it is not regulated by calcium, therefore NOS2 activity is 
regarded as calcium-independent [141, 171]. There are only a few intracellular 
mechanisms that regulate NOS2 activity, which is generally considered to be at the 
transcriptional level. The NOS2 protein levels can be acutely induced [154] and this 
enzyme is characterised by release of large quantities (at μM) of NO even hours after 
exposure to inducing agents [172, 173]. 
 Apart from calcium, several other factors can regulate NOS activity, especially 
NOS3 activation. NOS3 can be activated by certain stimuli without a sustained increase 
in calcium being necessary [169]. At the post-translational level, NOS3 activity is highly 
regulated by substrate and cofactor availability as well as endogenous inhibitors, lipid 
modification, direct protein-protein interactions, phosphorylation, O-linked 
glycosylation, and S-nitrosylation. The NOS3 signalosome is perhaps the best 
characterized of the three NOS isoforms since it has been clear for  a few years that the 
association with calmodulin and caveolin has profound effects on the intracellular 
localization and activity of NOS3 [162, 169, 174]). This enzyme can be phosphorylated 
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on serine, threonine, and tyrosine residues, with numerous putative phosphorylation 
sites (Figure 9). 
 
 
Figure 9. The regulation of NOS3 by phosphorylation. Schematic depiction of 
confirmed NOS3 phosphorylation sites, and their influence on enzyme activity (green 
arrows activation, red arrows inhibition, black arrow no direct effect on enzyme 
activity). The numbers refer to the human sequence (Taken from [169]. 
 
3.2 Nitric oxide chemistry  
 Nitric oxide is a simple, diatomic and non polar molecule. It is a colourless gas 
at room temperature and pressure. This inorganic free radical is also endogenously 
produced as a gas with a very short half-life from milliseconds to few minutes [141, 
175]. Although NO has a very short half-life, due to its high solubility, NO can freely 
diffuse through biological membranes. Its chemistry and redox state nevertheless 
facilitate its interaction with various biomolecules to regulate different intracellular and 
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intercellular events. In this section a few illustrative examples of the reactivity of NO 
will be presented. 
 
 3.2.1 NO redox species and its interactions 
 Nitric oxide either diffuses directly to its target or it is converted to different 
derivates. One of the most unique and important chemical features of NO is that it is a 
paramagnetic species. Unlike other carbon, oxygen or nitrogen-centred radicals, NO 
does not have the tendency to dimerize at standard temperature and pressure, so it is 
capable of forming high-affinity-nitroso complexes with a variety of metal complexes 
[176]. In a general view, NO can be converted to a variety of nitrogen oxide species 
(NOx); to an organonitrosyl (E-NO) compound, where E is a sulfur-, nitrogen-, or 
carbon-containing moiety or to a metal-nitrosyl (M-NO) complex [175]. Some of these 
species are better suited for delivery of NO and others for longer-term storage. 
 From a biological point of view, some important reactions of NO are those with 
oxygen in its various redox forms. Nitric oxide gas reacts with O2 to form nitric dioxide 
gas (NO2), which dimerizes to dinitrogen tetroxide (N2O4). The N2O4 dismutates 
spontaneously in water and buffers at pH 7.4 to yield the stable end products nitrite 
(NO2−) and nitrate (NO3−). Estimation of NO2−, NO3− in aqueous biological samples is 
used to provide indirect means of estimating endogenous NO production [141, 177, 
178]. Other important nitrogen oxide is peroxynitrite (ONOO-), that is formed in vivo 
by the diffusion-limited reaction between NO and superoxide [179]. This anion is highly 
oxidizing and can even effect tyrosine nitration, resulting in a variety of 
pathophysiological effects ranging from inflammation to cancer [180].  
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3.3 Nitric oxide biology  
 The NO synthesized within the cells  freely diffuses through the membranes and 
acts as an intracellular and extracellular biological messenger, interacting with a variety 
of biomolecules such as enzymes, cytokines, membrane receptors, transcription factors 
and DNA to modulate several physiological and pathological processes in mammals and 
other living organisms [181]. The roles exerted by NO, however, may vary according to 
its concentration, when and where it is produced, and whether NO acts directly or via 
some of its redox species as cited above [175, 182].The effects and the mechanism of 
action of NO are strictly dependent on its concentration as well as on the presence of 
metals, proteins and low-molecular-weight thiols in a given cell. For this reason NO 
may exert dual effects on the same process in the same cell. 
 
3.3.1 Mechanisms of action of NO   
 Nitric oxide has the capacity to modulate the activity of proteins through 
reversible reactions with available functional groups, notably with iron and thiols [175, 
176]. NO can directly react with heme proteins such as cytochrome P450 [183-185], 
cyclooxygenase [186, 187] and guanylyl cyclase [182, 188]. This last one was one of the 
first targets identified for NO in biology. Soluble guanylyl cyclase (sGC) is a 
heterodimeric enzyme consisting of α- and β- subunits and a prosthetic heme group with 
ferrous iron [189]. It has been proposed that unique binding interactions of NO with the 
heme iron in guanylate cyclase allows the liberation of the transaxial ligand, histidine, 
which leads to enzyme activation that catalyzes the conversion of GTP into guanosine 
3’5’-monophosphate (cGMP)[188]. The result is an increase in cGMP that represents an 
important intracellular second messenger that mediates many key biological actions of 
NO. The cGMP exerts its physiological actions through cGMP-dependent protein kinase 
(PKG), cGMP-regulated phosphodiesterases (PDE2, PDE3) and cGMP-gated cation 
channels, among which PKG might be the primary mediator. Importantly, the cGMP 
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signal is compartmentalized within a cell so that specific targeted proteins can be 
regulated by the same “generic” cGMP to exert differential physiological effects. 
 Although initially the physiological effects of NO were thought to be 
predominantly related to the activation of guanylate cyclase and thus to enhanced 
production of cGMP, the influence of NO in normal cellular function as well as in a 
wide range of pathophysiological conditions has been linked to S-nitrosylation [190]. In 
this process, NO modifies protein functions via covalent attachment of a NO group to 
reduced thiol (Cys) groups of free amino acids, peptides and proteins to form a S-
nitrosothiol or S-nitrosoprotein [191]. S-nitrosylation seems to be one of the principal 
post-translational protein modifications that play a role in cell signaling, including 
phosphorylation, acetylation and ubiquintylation [192].   
 
3.3.2  Roles of nitric oxide in general physiology  
 The NOS enzymes have been found in a variety of cell types, including 
neurons, gastric and bronchial epithelium, skeletal muscle, macrophages, 
cardiomyocytes, hepatocytes, chondrocytes and many others tissues and cells types of 
living organisms. The production of NO is, therefore, almost ubiquitous and NO seems 
to be associated with a wide range of functions. The known roles of NO in biology 
continue to grow and now range from neuroprotection and the immune response to 
protein regulation and chemotherapeutic resistance [193-195], vasodilation, maintaining 
the endothelial cell barrier, inhibition of platelet aggregation and neutrophil adhesion to 
endothelial cells [196], reduction of smooth-muscle cell proliferation and migration 
[197] and the control of apoptosis [198]. 
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3.3.3 Roles of nitric oxide in general physiopathology 
 NO exerts important roles in carcinogenesis and tumor progression. It has been 
demonstrated that NO may be both pro- and anti-tumorigenic, depending on the 
concentration and the tumor microenvironment in question [199]. This free radical is 
involved in immune system responses and pathogenesis of several disorders. NO may 
act as a critical agent of host defense, but also as a central mediator of different 
pathogenesis. As mentioned previously some of the NO actions must depend on what 
sort of cell, which NOS is involved and NO interactions. High levels of NO inhibit a 
wide array of microorganisms, but can also potentially damage the host, contributing to 
the pathology [200]. Generally, the NOS normally associated with many pathologies is 
the inducible enzyme, NOS2. The production of NO by NOS2 is higher than that from 
other NOS enzymes, so concentration can easily increase up to cytotoxic levels. The 
antimicrobial effect may be also consequence of the formation of reactive nitrogen 
intermediates. Nitric oxide can react with other radicals, resulting in the formation of 
peroxynitrite, a potent oxidant effective in inducing cytotoxicity. These molecules 
induce oxidative and nitrative stress to kill intracellular microorganisms as part of the 
innate immune response [201].  
 As mentioned in a previous section, NO may modulate, at different levels, the 
activity of cyclooxygenases, precursor enzymes of PGs synthesis [186, 202]. Although 
the basal release of NO and PGs exerts a protective role in many pathophysiological 
conditions, NO and PGs released simultaneously in large amounts may be detrimental 
for cell survival. The overt production of NO and PGs is now known to occur in tissues 
affected by the inflammatory processes of rheumatic diseases, chronic degenerative 
disorders, central neurodegenerative processes associated with brain ischemia, as well as 
in neuroinflammatory diseases [187].  
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3.4 Nitric oxide functions in the ovary  
 NO has been also implicated in the regulation of mammalian reproduction.  
Specifically in the female, it has been demonstrated that NO is generated by ovarian 
cells and within the ovarian vasculature. The involvement of NO in the modulation of 
ovarian function is documented by several studies which indicate that NO exerts critical 
roles in the regulation of steroidogenesis, follicle development and survival, ovulation, 
oocyte maturation, cumulus expansion and corpus luteum function and lifespan [7, 8, 
203].  
 
3.4.1 Nitric oxide and steroidogenesis  
 The involvement of NO in steroid secretion by the ovaries has been evaluated in 
many studies through the use of exogenous NO donors and/or NOS inhibitors. Several 
studies indicate a negative correlation between NO and steroidogenesis. The negative 
effect on steroid production by NO has been demonstrated in different species and in 
different conditions. NO appears to inhibit steroidogenesis in human granulosa–luteal 
cells [204], rat granulosa cells [205] and porcine granulosa cells [206, 207]. The action 
of NO is, in part, attributable to the down-regulation of CYP19 gene transcription, but 
NO may also directly inhibit aromatase activity probably by binding to the CYP19 heme 
portion and then altering the enzyme activity [208, 209]. In addition, some authors 
suggest that the negative effect of NO on both basal and gonadotropin stimulated 
estradiol production may be, at least in part, exerted through an inhibition of 
androstenedione secretion [210]. Another mechanism by which NO may regulate 
steroidogenesis in granulosa cells is through cGMP. The cGMP pathway was indicated 
as one of the mechanisms used by NO to inhibit steroidogenesis in cultured granulosa 
cells from mice [205]. It has been suggested that cGMP increases phosphodiesterase 2 
(PDE2) activity which in turn increases cAMP hydrolysis, the FSH intracellular second 
messenger. In swine, while some studies indicate that the effect of NO on 
steroidogenesis seem to be induced, at least in part, via a cGMP-dependent pathway 
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[207], others suggest it is not [211]. Studies with bovine granulosa cells also show that 
NO donors reduce estradiol and progesterone secretion, but the use of cGMP analogs 
did not efficiently inhibit steroidogenesis [212]. Interestingly, a more recent study with 
bovine granulosa cells indicates that high concentrations of the nitric oxide donor 
sodium nitroprusside (SNP) inhibited both progesterone and estradiol synthesis by 
cGMP-independent pathways, while low SNP concentrations stimulated E2 synthesis 
through the activation of soluble nitric oxide-sensitive guanylyl cyclase [213].  
 Some reports demonstrate the existence of a positive correlation between NO 
and steroid secretion. Follicular NOx (NO metabolites: nitrite plus nitrate) levels and 
estradiol concentration increased concomitantly in porcine ovarian follicles [214]. A 
similar relationship between NOx and estradiol concentrations is found in human 
ovarian follicles [215]. The increase of nitrite and nitrate levels in the serum of 
postmenopausal women subjected to E2 replacement therapy substantiates the positive 
effect of estrogens on NO production [216]. Estradiol has been reported to induce NOS3 
in cultured endothelial cells [217] and it has been shown that estrogen induced 
vasodilation and increased blood flow is mediated via NO generation [218]. 
Additionally, ovarian perfusion with a NOS inhibitor in rats causes decreased  E2 
synthesis, suggesting that appropriate NO concentrations may positively regulate E2 
synthesis [219].   
 
3.4.2 Nitric oxide production and follicle development and growth  
 An involvement of NO production in follicle growth has been indicated in some 
species. In women, NO levels change during follicular growth and a positive correlation 
between follicular NOx concentrations and follicular size was reported [215, 216]. NO 
seems to be necessary for follicle development in mice too. Reduced growth rate and 
persistent basement membranes were associated with in vitro disruption of NO [220]. 
Some authors suggest that NO may influence follicle development by mediating the 
effects of gonadotropins on the blood-follicle barrier, thus influencing its permeability to 
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different substances [221], but other evidence indicates that NO acts at a molecular level 
to regulate follicle development and growth. A growth promoting effect of NO is 
supported by the observation that NO increased, while NOS blockers reduced the 
expression of EGF receptors in rat granulosa cells [222]. However, treatment of bovine 
granulosa cells from different size follicles with the NO donor S-nitroso-N-
acetylpenicillamine (SNAP) did not influence granulosa cell proliferation [223].  
 
3.4.3 Nitric oxide and apoptosis in granulosa cells 
 A further mechanism through which NO may be involved in the control of 
follicular development is its effects on apoptosis [224]. Although NO exerts pro-
apoptotic properties in many cell types [198, 225], a protective effect of NO has been 
observed in rat granulosa cells from immature [226, 227] and preovulatory [228] 
follicles. It is reported that NO inhibits FasL-induced apoptosis in rat granulosa cells by 
suppressing the activation of caspases [229]. Moreover, some reports show that NO 
donors decreased the expression of genes as Bax, a pro-apoptotic member of the Bcl-2 
protein family [228]. In human granulosa cells, different data have been reported and do 
not clearly define NO involvement in the regulation of apoptosis [230]. On the other 
hand, high NO levels have been shown to reduce apoptosis in bovine granulosa cells 
[223]. In this same species, the addition of SNAP also decreases significantly the 
number of apoptotic nuclei in blastocysts [231]. This confirms that NO may exert a cell 
protective function, as suggested in a study with bovine embryos [232].  
  
3.4.4 Nitric oxide and the ovulatory process 
 Studies performed with different species and using different approaches, provide 
strong evidence that NO also participates in the ovulatory process. Although one study 
in rats suggested that a preovulatory decrease in NO concentrations is a prerequisite for 
the ovarian response to LH and successful ovulation [233], most of the reports indicate 
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that NO is an essential mediator of ovulation. In rats, the administration of NOS 
inhibitors, intraperitoneally or via the ovarian bursa, inhibits ovulation, an effect 
reversed by a NO donor [234]. Similar results have been reported in hCG-treated rabbits 
[235, 236]. Studies conducted on NOS knockout mouse models provide further support 
for the role of NO in ovulation. NOS3 deficiency in the mouse has been shown to be 
associated with a significant reduction in ovulatory potential after hCG treatment [237-
239] 
 It has been suggested that NO might contribute to follicle rupture by increasing  
intrafollicular pressure [240], either by increasing the vascular flow and the transudation 
of fluid to the follicular antrum or by stimulating the contractile elements of the ovarian 
follicle. But the most relevant mechanism by which NO stimulates the ovulatory process 
probably involves the production of prostaglandins, which contribute to enhancing the 
inflammatory process in the periovulatory period. In different cell types and tissues, it 
has been shown that NO regulates PTGS2 at the level of transcription, translation and 
enzyme activity [187]. PTGS2 is activated by NO at lower concentrations via binding to 
the heme moiety and so augmenting enzymatic activity [186, 241], whereas higher 
concentrations of NO may inhibit both synthesis and activity of PTGS2 [242]. A 
crosstalk between NO and PG biosynthetic pathway has been reported in the ovary. 
Blocking intraovarian NO production by NOS inhibitors diminished the production of 
PGE2 and PGF2α in response to hCG injections, while intrabursal injection of NO 
donor stimulated prostaglandin synthesis in rabbits [235] and rats [243]. A stimulatory 
effect of a NO donor on PGF2α production by large bovine follicles has been also 
reported [244].  
 
3.4.5 Nitric oxide and oocyte maturation  
 Nitric oxide synthesis seems to be also important for oocyte maturation. NOS3 
knockout mice exhibited a reduced number of oocytes in metaphase II of meiosis; a high 
percentage of oocytes remained in metaphase I or were atypical compared to controls 
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[237]. The effects of NO on oocyte maturation have also been evaluated by the use of 
NO donors. However, the effect of NO generated by an exogenous donor on mouse 
oocyte maturation can be stimulatory or inhibitory depending on its concentration. NO 
inhibited [237] or stimulated [245-249] nuclear maturation in mice. Besides NO donors, 
several drugs that inhibit NO synthesis are being used in studies on ovarian physiology, 
and they show that manipulating amounts of NO during in vitro culture also affects 
oocyte maturation in cattle [250]. One of these studies indicated that the accumulation of 
cGMP was probably not responsible for the effects of NO on meiosis [251]. NO affects 
the in vitro maturation of bovine COC, modulating the viability of cumulus cells and of 
oocyte, the progression of meiosis after GVBD, the migration of cortical granules, and 
cleavage and blastocyst development [252]. Another study with bovine ovaries suggests 
that a defective NOS3/NO system is related to a reduced follicle vasculature and may 
affect oocyte quality, thus inducing a premature decline of fertility [231].  
 
3.4.6 Nitric oxide and corpus luteum formation and luteolysis  
   Nitric oxide is also involved in the regulation of corpus luteum formation, 
function and lifespan. Different studies indicate, however, that action of NO may 
depend on the stage of CL development. In rats, a positive effect of NO has been 
suggested in the midstage CL. NO stimulated both glutathione, a major antioxidant, and 
progesterone production, thus favoring the maintenance of the CL [253]. It has been 
suggested that NO is also possibly involved in the control of luteal vascularization 
[254]. Together with PGE, NO seems to act through its effects on vasculature and 
proteolytic processes [255]. Other findings indicate that NOS2 mediated NO secretion 
stimulated PGE synthesis, which is effective in increasing progesterone production 
[256]. Prostaglandin E has been demonstrated to enhance basal progesterone secretion 
also in newly formed CL from pseudopregnant rabbits [257]. In mares, it is suggested 
that NO may play a role in CL growth during early luteal development, when vascular 
development is more intense [258]. 
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 On the other hand, NO has been suggested to be an important mediator of 
luteolysis in several species. NO produced by the rat ovaries during the last 2 days of 
CL development increased PGF2α production in the ovary and diminished serum 
progesterone concentrations leading to CL involution [253, 259]. In cattle, NO 
stimulated the synthesis of PGF2α, which in turn increased NOS activity, thus activating 
a positive feedback mechanism between PGF2α and NO to ensure luteal regression and, 
consequently, progesterone production decrease [260, 261]. The same has been 
suggested in humans [262] and rabbits [257].  
 
3.5 NOS expression in the ovary  
 The expression and activity of NOS vary in the ovary and may depend on 
stimulus, cell type and animal species involved [7]. Although NOS3 was initially, with 
NOS1, considered as constitutively expressed, it is has been established that their 
expression can be regulated at the transcriptional level under various conditions [263]. 
In contrast, the expression of NOS2 is considered inducible, mainly in response to 
immune stimulus, as inflammatory cytokines [137]. But other non-inflamatory stimulus 
may influence on NOS2 expression, as it will be described in this section. 
 
3.5.1 Nitric oxide synthases identified in the ovary  
 In most  studies in NOS expression in reproductive tissues, NOS2 and NOS3 are 
the enzymes commonly detected in follicles, while NOS1 is normally poorly or not 
detected. In rats, NOS3 was detected in oocytes, granulosa cells of immature and 
gonadotropin-stimulated ovaries [264] and in blood vessels [265]. NOS2 was also 
detected in rat granulosa cells [226, 265] and a study demonstrated that both NOS2 and 
NOS3 are expressed in rat stroma, thecal and luteal cells [266]. In mice, both NOS3 and 
NOS2 were localized in oocyte, theca and granulosa cells [220, 248, 267]. In humans, 
NOS3 expression was reported in granulosa-luteal cells [204]. In porcine follicles, 
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NOS3 was localized in oocytes, cumulus cells, and granulosa cells and NOS2 was 
mainly localized in the oocytes, granulosa and theca cells [268-270]. 
 In cattle, the situation is not clear. While some studies demonstrated that NOS3 
protein was not detected in granulosa cells of growing follicles from cattle [271], and 
mRNA encoding NOS2 was not detected in cultured bovine granulosa cells [272], other 
studies were published indicating that NOS were identified in ovarian cells [231, 273, 
274]. According to these authors, both NOS3 and NOS2 were detected in oocytes, 
granulosa and theca cells and other compartments of the ovary, including corpus luteum, 
corpus albicans, surface epithelium and stroma.  
 
3.5.2 NOS expression during follicle development  
 The expression of NOS2 and NOS3 is regulated by gonadotropins and other 
factors in the ovarian cells of different species, suggesting that both participate in the 
ovarian functions. In immature rats, follicular development induced by pregnant mare's 
serum gonadotropin (PMSG) is associated with an increase in NOS3, while NOS2 
expression remains relatively constant [264, 265]. On the other hand, some authors 
observed a decrease in NOS2 mRNA levels induced by PMSG in granulosa cells from 
immature rat follicles and suggest that NO may act as a cytostatic factor [226]. In 
cultured rat granulosa cells, FSH does not induce NOS2 mRNA, but interleukins induce 
activation of NOS2 [226, 275].  
 In porcine granulosa cells of antral follicles, the endothelial NOS was expressed 
only in the presence of FSH [207, 269]. Studies of pig oocytes from small follicles (1–3 
mm) showed that amounts of NOS3 protein were constant after culture [268], while 
amounts of NOS2 protein decreased [214], suggesting a differential gene expression 
during follicular development. In sheep, it was reported that NOS3 mRNA and protein 
expression changes throughout follicular growth and atresia, and the pattern for NOS3 
protein expression follows the pattern of vascular development during folliculogenesis 
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[276]. In cows, NOS3 protein was detected in granulosa cells during all the stages of 
folliculogenesis [274]. 
 
3.5.3 NOS expression during peri-ovulatory period   
 In rats, stimulation with hCG induces an increase of both NOS2 and NOS3 [264, 
266]. In pigs,  low levels of NOS3 were detected in oocytes and granulosa cells at the 
early stage of follicle development in comparison to NOS3 levels in both cell types in 
preovulatory follicles [277]. In cattle, NOS3 and NOS2 transcripts were detected in 
oocytes, however, relative abundance of these transcripts decreased after in vitro 
maturation [274]. Other studies made similar observations and suggested that the 
reduction in NOS3 transcript could be involved in the reduction in NO necessary for 
germinal vesicle breakdown [273, 278].  
 
3.5.4 NOS expression during CL formation and luteolysis  
 The expression as well activity of NOS enzymes may change from CL formation 
up to its regression. In rats, NOS2 expression decreased with CL aging [279]. NOS2 
expression also declined with CL aging in the rabbit [280, 281] and sheep [254]. In the 
human CL, NOS3 is the most abundant NOS with highest values during the late luteal 
phase, but immunoreactive NOS2 did not show well defined phase-specific changes 
[262]. In bovine CL, it was possible to detect NOS2 and NOS3 in endothelial and luteal 
cells. The levels of NOS3 and NOS2 were increased from the early to late luteal phase 
of the estrous cycle and then decreased in regressed luteal phase in the cow [282].  
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Hypotheses and objectives 
 
 The pattern of NOS enzyme expression in the follicle of ruminants is not clear. 
In cattle, the expression of NOS genes in granulosa cells is controversial, but it has been 
demonstrated that FSH stimulates NO production in cultured bovine granulosa cells and 
that the inhibition of endogenous NOS activity decreased bovine cumulus cell viability 
and affected oocyte maturation. These findings indicate the existence of endogenous 
NOS activity in the granulosa layer of this species.  
 Studies indicate that nitric oxide may present anti-apoptotic properties. In 
rodents, nitric oxide suppressed follicle apoptosis, decreasing both mRNA and protein 
levels of pro-apoptotic genes. Considering that during follicle growth in cattle, one 
follicle is selected for further growth and the other follicles in the cohort regress and 
undergo atresia through apoptosis our first hypothesis is that NOS are expressed in 
bovine granulosa cells under regulation by gonadotrophic hormones, and its activity 
may be related to granulosa cell survival.   
 Nitric oxide has been also correlated with ovulation. In studies performed with 
different polyovulatory species, inhibition of NO production blocks induced ovulation. 
It is suggested that the most relevant mechanism by which NO stimulates the ovulatory 
process probably involves the production of prostaglandins. Therefore, our second 
hypothesis is that NOS expression and activity is critical for expression of genes 
essential for the ovulatory cascade in bovine granulosa cells.  
 To test the hypotheses mentioned above we established the following objectives 
for the present thesis: 
 1. To elucidate some of the mechanisms controlling NOS expression and the 
consequences of nitric oxide production for granulosa cell function during follicular 
development in bovine. 
 2. To determine the regulation of NOS expression during the LH-induced 
ovulatory cascade in bovine granulosa cells, and to assess whether NOS activity is 
critical for the expression of genes involved in the ovulatory cascade in this species.  
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Regulation of inducible nitric oxide synthase expression in bovine ovarian 
granulosa cells. 
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Abstract 
Nitric oxide (NO) is a potential regulator of ovarian follicle growth, and ovarian 
granulosa cells reportedly generate NO in response to gonadotrophins, suggesting that 
the regulated form of nitric oxide synthase (iNOS) is present. The objectives of the 
present study were to gain insight into the expression and role of iNOS in the follicle. 
Messenger RNA encoding iNOS was detected in granulosa cells, and abundance was 
higher in growing dominant follicles compared to subordinate follicles (P<0.01). FSH 
(P<0.05) and IGF1 (P<0.01) stimulated oestradiol secretion and iNOS mRNA 
abundance in granulosa cells in vitro, whereas FGF2 (P<0.05) and EGF (P<0.01) 
decreased oestradiol secretion and iNOS expression. The addition of an anti-oestrogen 
prevented FSH-induced iNOS mRNA accumulation. Inhibition of endogenous NO 
production did not affect steroidogenesis in granulosa cells, but increased FasL mRNA 
abundance, caspase-3 activation and the incidence of apoptotic cell death (P<0.05). 
These results demonstrate that iNOS is expressed in ruminant granulosa cells and is 
regulated by gonadotrophins and oestradiol. Physiological levels of NO may contribute 
to the survival of granulosa cells. 
 
 Key words: ovary, nitric oxide, follicle, steroidogenesis, apoptosis 
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Introduction 
In monovulatory species, follicle growth occurs in waves, and a cohort of follicles 
arises in each wave under the influence of a transient rise in circulating FSH 
concentrations. As FSH concentrations decline, only one follicle will be ‘selected’ for 
continued growth; all the others will become atretic. The continued growth of the 
dominant follicle has been linked to increased IGF1 bioavailability and oestradiol 
production (Beg et al., 2002; Fortune et al., 2004). A variety of paracrine signalling 
molecules has also been implicated in the regulation of follicle growth (Buratini & 
Price, 2011; Webb et al, 2007), and there is a growing awareness of potential roles for 
intracrine effectors such as nitric oxide. 
Nitric oxide (NO) is a free radical gas produced by the conversion of L-arginine to 
L-citrulline by a family of nitric oxide synthases (NOS). Nitric oxide is generated in 
most organ systems, including the major reproductive tissues (Rosselli et al., 1998). The 
predominant NOS enzymes present in reproductive tissues are endothelial (eNOS, also 
known as NOS3) and inducible NOS (iNOS, also known as NOS2); the expression of 
eNOS is commonly constitutive whereas that of iNOS is considered to be regulated. The 
importance of NO in fertility has been demonstrated with studies of knockout mice, in 
which loss of either eNOS or iNOS disrupted oestrous cyclicity (Jablonka-Shariff et al., 
1999). The viability of double eNOS/iNOS knockout mice is severely compromised 
(Tranguch and Huet-Hudson, 2003). 
A number of studies suggest that NO affects ovarian function. High concentrations 
of NO in follicular fluid have been associated with reduced oestradiol secretion and 
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lower oocyte quality in women undergoing in vitro fertilization (Lee et al., 2004; 
Vignini et al., 2008). Similarly, the addition of NO donors to follicular granulosa cells in 
vitro inhibited steroidogenesis in humans, pigs, rats and cattle (Basini et al., 1998; 
Masuda et al., 1997; Snyder et al., 1996; Van Voorhis et al., 1994). Some evidence also 
indicates that NO inhibits the expression of genes responsible for triggering the 
apoptotic cascade, at least in rats (Chen et al., 2005; Yoon et al., 2002).  
The pattern of NOS enzyme expression has been described in the follicle in 
polyovulatory species. In rats, iNOS mRNA was located to granulosa cells of immature 
but not antral follicles (Matsumi et al., 1998; Van Voorhis et al., 1995), whereas eNOS 
mRNA was detected in granulosa cells of gonadotrophin-stimulated antral follicles 
(Jablonka-Shariff and Olson, 1997). Similarly in pigs, eNOS but not iNOS mRNA has 
been measured in granulosa cells from antral follicles (Grasselli et al., 2001; Takesue et 
al., 2001), although iNOS protein was detected in granulosa cells in one 
immunohistochemistry study (Kim et al., 2005) but not in another (Tao et al., 2004).   
In contrast, the situation in monovulatory species is not clear. Endothelial NOS 
protein was not detected in granulosa cells of growing follicles from sheep and cattle 
(Grazul-Bilska et al., 2006; Grazul-Bilska et al., 2007), and mRNA encoding iNOS was 
not detected in cultured bovine granulosa cells (Herath et al., 2007). These data are 
puzzling as FSH stimulated NO production in cultured bovine granulosa cells (Basini 
and Tamanini, 2000), and inhibition of endogenous iNOS activity with aminoguanidine 
decreased bovine cumulus cell viability (Matta et al., 2009). These latter findings argue 
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for the existence of endogenous, inducible NOS activity in the granulosa layer of 
monovulatory species. 
We hypothesise therefore that iNOS is expressed in bovine granulosa cells, and is 
under regulation by gonadotrophic hormones. The objectives of the present study were 
to determine the hormonal regulation of iNOS expression in granulosa cells in vitro, to 
investigate the physiological role of NO in granulosa cells in vitro by inhibiting 
endogenous iNOS activity, and to extend these studies to an in-vivo model of follicle 
growth and atresia.  
 
Materials and methods 
 
In vitro studies 
To study the regulation of iNOS expression and role of nitric oxide on granulosa 
cell function, we cultured granulosa cells in serum-free medium as described (Gutiérrez 
et al., 1997) with slight modifications. Materials were obtained from Invitrogen Life 
Technologies (Burlington ON, Canada) unless otherwise stated. Briefly, bovine ovaries 
were collected from adult cows at abattoir, and were transported to the laboratory in 
 PBS containing penicillin (100 IU/ml) and streptomycin (100 μg/ml). Follicles between 
2 and 5 mm diameter were dissected and granulosa cells were collected by rinsing the 
follicle wall with Dulbecco’s Modified Eagle Medium Nutrient Mixture F-12 
(DMEM/F12). The granulosa cells were washed twice by centrifugation at 980 g for 20 
min each, and either frozen in Trizol for RNA extraction or suspended in DMEM/F12 
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containing Hepes (15 mM), sodium bicarbonate (10 mM), sodium selenite (4 ng/ml), 
BSA (0.1 %; Sigma-Aldrich, Oakville ON, Canada), penicillin (100 IU/ml), 
streptomycin (100 μg/ml), transferrin (2.5 μg/ml), non-essential amino acid mix (1.1 
mM), androstenedione (A4; 10−7 M at start of culture, and 10−6 M at each medium 
change) and insulin (10 ng/ml). The number of cells was counted with a 
haemocytometer and the viable cells were assessed by the dye exclusion method using  
0.4 % Trypan Blue. Cells were seeded into 24-well tissue culture plates (Sarstedt Inc; 
Montréal QC, Canada) at a density of 1x106 viable cells per well in 1 ml medium. 
Cultures were maintained at 37 °C in 5 % CO2 in air for 6 days, with 700 μl medium 
being replaced every 2 days. Depending on experiment, cells were treated with insulin 
like growth factor 1 (IGF1; LongR3 analogue), fibroblast growth factor-2 (FGF2), ICI 
182780, aminoguanidine (all from Sigma-Aldrich), epidermal growth factor (EGF; 
R&D Systems, Minneapolis, MN) and/or bovine FSH (lot AFP-5332B; Dr Parlow, 
NIDDK). All hormonal treatments were started on day 2 of culture. Medium samples 
were collected on day 6 and stored at −20 °C until steroid assay, and cells were collected 
in Trizol and stored at −80 °C until RNA extraction. All series of cultures were 
performed on at least three different pools of cells collected on different occasions. 
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In vivo study 
To determine if iNOS expression differs between growing and regressing follicles 
in vivo, follicles were collected from cycling cows at defined stages of follicle growth. 
The experimental animals were obtained from a herd of Angus cattle on a farm in the 
State of Rio Grande do Sul, Brazil. The experimental procedures were approved by the 
Federal University of Santa Maria Animal Care and Use Committee. Ovulation and 
subsequent emergence of the first follicular wave of the cycle were induced by an 
injection of prostaglandin-F2α as described (Evans and Fortune, 1997). The animals 
were slaughtered at a local abattoir during the first follicle wave around the expected 
time of follicle deviation, and the ovaries were transported to the laboratory.  
The two largest follicles from each pair of ovaries were dissected and their 
diameter was measured. Cows with a follicle greater than 10 mm were likely post-
deviation and were not used. The follicular fluid was aspirated, centrifuged and frozen 
for steroid assay. The antral cavity was repeatedly flushed with saline solution and 
granulosa cells recovered by centrifugation at 1200 g for 1 min and pooled with the 
follicular fluid pellet. The samples were collected into Trizol and the total RNA was 
extracted immediately according to the manufacturer’s protocol. A total of 12 follicles 
from six cows were used. The dominant follicle in each animal was identified by 
follicular fluid oestradiol concentration and evaluation of mRNA encoding cytochrome 
P450 aromatase (CYP19A).  
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Real-time RT-PCR 
For both in vivo and in vitro samples, gene expression was assessed by relative 
real-time RT-PCR. Total RNA (1 μg for cultured samples and 0.2 μg for in vivo 
samples) was first treated with 1U DNase (Promega, Madison, WI USA) at 37 °C for 5 
min to digest any contaminating DNA. The RNA was reverse transcribed in the 
presence of 1 mM oligo(dT) primer and 4 U Omniscript Rtase (Qiagen, Mississauga, 
ON Canada), 0.25 mM dideoxy-nucleotide triphosphate (dNTP) mix, and 19.33 U 
RNase Inhibitor (GE Healthcare, Baie-d’Urfé, QC Canada) in a volume of 20 μl at 37 
°C for 1 h. The reaction was terminated by incubation at 93 °C for 3 min. Real-time 
PCR was conducted in an ABI Prism 7300 instrument in 25 μl reaction volume 
containing 12.5 μl of 2X Power SYBR Green PCR Master Mix (Applied Biosystems, 
Foster City, CA), 9.5 μl of water, 1 μl of each sample cDNA and bovine-specific 
primers for amplifying histone H2AFZ (Portela et al., 2010), CYP19A (sense primer 2a, 
antisense 3b) (Hamel et al., 2005), iNOS (Tesfaye et al., 2006), and FasL (sense: 5’-
AGCCAAAGGCATAC -3’, antisense: 5’-TGCCTGTTAAATGA-3’). A common 
thermal cycling parameter (3 min at 95 °C, 40 cycles of 15 s at 95 °C, 30 s at 60 °C and 
30 s at 72 °C) was used to amplify each transcript. Identity of the iNOS amplicon was 
confirmed by sequencing; there was no significant homology with bovine eNOS or 
nNOS sequences. Melting curve analyses were routinely performed to verify product 
identity. Samples were run in duplicate and were expressed relative to H2AFZ as 
housekeeping gene. Data were normalised to a calibrator sample (a mix of cDNA 
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samples from cultured granulosa cells) using the ∆∆Ct method with correction for 
amplification efficiency (Pfaffl, 2001).  
 
Apoptosis assessment 
Apoptosis in cultured cells was measured by flow cytometry and 
immunofluorescence for cleaved caspase-3. Flow cytometry was performed essentially 
as described (Blondin et al., 1996). After culture,  cells were recovered by scraping the 
plate with a rubber spatula. The cells were washed 3 times in ice-cold PBS by 
centrifugation and resuspending the cells, then fixed overnight in 70 % ethanol before 
staining with propidium iodide (50 mg/mL in PBS with 0.1 % Triton X and 20 mg/mL 
RNase A). A minimum of 25,000 propidium iodide stained cells/sample were sorted on 
a FACSVantage SE (BD Biosciences, Oakville ON, Canada) and analysed with Cell 
Quest Pro software (BD Biosciences). The number of cells in the ‘‘sub-G1’’ peak was 
quantified and represented the number of apoptotic cells. Proportions of apoptotic cells 
were transformed to arcsines before statistical analysis. 
For immunofluorescence, cultured cells were fixed in 4 % paraformaldehyde for 
20 min, washed in 2 % Triton-X and and then in 0.05 % Tween, blocked in 5 % BSA, 
and incubated with cleaved caspase-3 antibody (1:150; Cell Signaling Technology, 
Danvers MA). After the primary antibody, the cells were washed in PBS and then 
incubated with Cy3-conjugated second antibody (Jackson ImmunoResearch, West 
Grove, PA) and counterstained with DAPI. Cells were examined under an Olympus 
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FV1000 laser-scanning confocal microscope with multi-argon laser light source. Digital 
images were captured and mean fluorescence intensity in each field for Cy3 and DAPI 
were quantified with ImageJ software (NIH). Results are expressed relative to DAPI. 
Steroid assay 
Oestradiol was measured in follicular fluid and conditioned medium in duplicate 
by RIA as described previously (Bélanger et al., 1990), without solvent extraction. Intra- 
and inter-assay coefficients of variation were 6% and 9%, respectively. The sensitivity 
of this assay was 10 pg/tube, equivalent to 0.3 ng/μg protein. Steroid concentrations in 
culture medium were corrected for cell number by expressing per unit mass of cell 
protein. Cells were lysed with 100 μl 1 N NaOH for 2 h and neutralised with 100 μl 1N 
HCl, and total cell protein was measured by the Bradford protein assay (Bio-Rad, 
Mississauga, ON, Canada).  
 
Statistical analysis 
The in-vivo data were analysed by ANOVA with follicle group as a main effect. 
For the in-vitro data, doses of hormones and growth factors were used as the main 
effects and culture replicate was included in the model as a random effect in the F-test. 
Data were transformed to logarithms when not normally distributed (Shapiro–Wilk test). 
Differences between means were tested with the Tukey–Kramer HSD test. All analyses 
were performed with JMP software (SAS Institute, Cary, NC). Data are presented as 
means ± SEM. 
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Results 
iNOS mRNA abundance is under hormonal regulation 
We first investigated the regulation of iNOS mRNA abundance in granulosa cells 
using a non-luteinising culture model. In this model, FSH and IGF1 stimulate cell 
proliferation and oestradiol secretion (Cao et al., 2006; Gutiérrez et al., 1997). Cells 
were cultured in the presence of graded doses of FSH or IGF1 for the last 4 days of 
culture. FSH stimulated oestradiol secretion and iNOS mRNA abundance in a dose-
dependent manner with an approximate 4-fold increase in iNOS mRNA levels (P<0.05, 
Fig. 1A). Similar effects were noticed for IGF1 (P<0.01, Fig. 1B).  
In a second series of cultures, cells were cultured in the presence of IGF1 (10 
ng/ml) with or without EGF (10 ng/ml), or with FSH (1 ng/ml) with or without FGF2 
(10 ng/ml). These growth factors were used at doses previously demonstrated to inhibit 
oestradiol secretion in this cell model (Cao et al., 2006), and they significantly decreased 
oestradiol secretion and iNOS mRNA levels in the present study (P<0.05, Fig. 1C, D).   
 
Oestradiol regulation of iNOS mRNA levels 
Increases in iNOS mRNA levels were generally accompanied by increased 
oestradiol secretion, therefore we determined if oestradiol had a direct effect on iNOS 
mRNA. First we cultured cells with graded doses of FSH with the aromatase substrate, 
A4, or with the non-aromatisable androgen, dihydrotestosterone (DHT; 1.0μM). In the 
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presence of A4, FSH stimulated oestradiol secretion and iNOS mRNA levels, but in the 
presence of DHT, FSH failed to stimulate oestradiol secretion (not shown) or iNOS 
mRNA (Fig 2A). We then cultured FSH- or IGF1-stimulated cells with the 
antioestrogen ICI 182,780 (10μM), which resulted in a marked decrease of iNOS 
mRNA abundance (P<0.05, Fig 2B). Conversely, culture with oestradiol (in the absence 
of FSH to minimise endogenous oestradiol secretion) significantly increased iNOS 
mRNA abundance (Fig 2C). 
 
Endogenous iNOS activity inhibits apoptosis 
To explore the role of NO, granulosa cells were cultured with IGF1 (10 ng/ml) 
with or without the selective iNOS inhibitor, aminoguanidine (1 mM). Addition of 
aminoguanidine had no consistent effect on steroid secretion (not shown) or CYP19 
mRNA abundance, but increased the proportion of apoptotic cells, cleaved caspase-3 
protein and abundance of mRNA encoding the pro-apoptotic factor Fas ligand (P<0.05, 
Fig 3). Aminoguanidine also increased the proportion of apoptotic cells cultured with 
FSH (not shown). 
iNOS mRNA is regulated during establishment of the dominant follicle in vivo  
The above studies in vitro suggest that iNOS mRNA levels are upregulated by 
IGF and that endogenous iNOS activity may contribute to granulosa cell survival. In 
cattle, the dominant follicle is characterised by a healthy layer of granulosa cells 
growing under the influence of IGF, therefore we determined if iNOS mRNA 
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abundance differs between growing and non-growing follicles using a well-defined in 
vivo model. There was no significant difference in mean diameters between dominant 
and non-dominant follicles of the first follicle wave (P>0.05, Fig. 4A), however the 
status of the dominant follicle was confirmed by higher oestradiol concentrations 
(P<0.01, Fig. 4B) and by higher levels of granulosa cell CYP19A mRNA (P<0.05, Fig. 
4C) compared to the non-dominant follicle. Abundance of iNOS mRNA in granulosa 
cells was higher in dominant follicles than in subordinate follicles (P<0.01, Fig. 4D).  
 
Discussion 
The physiology of nitric oxide in the bovine follicle was, until now, an enigma: 
nitric oxide is generated by granulosa cells (Basini et al., 1998) and regulated by FSH 
(Basini and Tamanini, 2000), and yet neither eNOS nor iNOS had been reported in this 
cell type (Grazul-Bilska et al., 2007; Herath et al., 2007). A recent study identified both 
proteins in granulosa cells by immunohistochemistry, but also in theca, stroma, surface 
epithelium and in corpora lutea and albicantia (Pires et al., 2009). In the present report, 
we describe the expression of iNOS in bovine granulosa cells in vivo and after serum-
free culture, and its regulation by FSH and IGF1. These data explain the ability of 
granulosa cells to generate NO, and offer insights into its physiological role. 
This is the first study to describe the presence of iNOS mRNA in ruminant 
granulosa cells. In contrast, Herath and colleagues could not dectect iNOS mRNA by 
PCR (Herath et al., 2007). The difference between studies is difficult to explain, as both 
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employed a similar serum-free culture system, although the primers for PCR were 
different. In the present study, iNOS mRNA was consistently detected in granulosa cells 
over the course of numerous cultures, and was also detected in granulosa cells of 
growing first-wave follicles. These data are consistent with the generation of NO in 
cultured cells (Basini and Tamanini, 2000). 
Abundance of mRNA encoding iNOS was regulated. FSH and IGF1 both 
increased iNOS mRNA abundance, and to our knowledge, no other similar studies have 
been reported. In rats, injection of eCG induced follicle development and NOS activity 
in whole-ovary extracts (Faletti et al., 1999), likely owing to an increase in thecal eNOS 
expression (Jablonka-Shariff and Olson, 1997). In the present study, EGF and FGF2 
inhibited iNOS mRNA abundance in granulosa cells, which is consistent with the effect 
of EGF on iNOS in cultured rat granulosa cells (Matsumi et al., 2000). A common 
observation in these experiments was that treatments that increased oestradiol secretion 
(FSH, IGF1) also increased iNOS mRNA abundance, whereas those that decreased 
oestradiol secretion (FGF2, EGF) decreased iNOS mRNA levels. 
To gain insight into the nature of the relationship between oestradiol and iNOS, 
we evaluated whether oestradiol directly alters iNOS mRNA levels. In the absence of an 
aromatisable substrate, FSH was unable to stimulate iNOS mRNA abundance, and 
blockade of oestradiol action caused marked down-regulation of iNOS mRNA levels in 
FSH- and IGF1-stimulated cells. Further, the addition of oestradiol directly stimulated 
iNOS mRNA accummulation. These data suggest that the effects of gonadotrophins and 
growth factors on iNOS mRNA are mediated at least in part by oestradiol. This is in 
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agreement with studies demonstrating regulation of eNOS/iNOS by oestradiol in 
uterine/oviductal tissue in humans, sheep and cattle (Guang et al., 2005; Lapointe et al., 
2006; Zhang et al., 1999).  
The function of NOS in the follicle remains to be clarified. In cultures of porcine 
(Masuda et al., 1997), bovine (Basini et al., 1998) and human (Van Voorhis et al., 1994) 
granulosa cells addition of NO donors inhibited steroidogenesis, leading to the general 
conclusion that NO is a negative regulator of follicle function. However, these data 
should be interpreted with caution, as NO donors have been shown to be cytotoxic (Faes 
et al., 2009; Viana et al., 2007). In the present study, we inhibited endogenous NO 
production with the selective iNOS inhibitor, aminoguanidine (Misko et al., 1993). We 
reasoned that reduced intracellular NO generation would increase follicle function, but 
aminoguanidine did not enhance oestradiol secretion or CYP19A mRNA levels, 
possibly because oestradiol secretion is already raised in these IGF1-stimulated 
granulosa cells (Glister et al., 2001; Gutiérrez et al., 1997; Silva and Price, 2000). It has 
also been suggested that NO inhibits apoptosis of granulosa cells (Basini et al., 1998; 
Matsumi et al., 2000; Yoon et al., 2002). One of the critical mediators of apoptosis in 
follicles is the Fas/FasL system, and NO inhibited FasL-induced apoptosis in rat 
granulosa cells (Chen et al., 2005). Consistent with these studies, we showed that 
inhibition of endogenous iNOS activity increased FasL mRNA abundance and increased 
the incidence of caspase-mediated apoptosis. Oestradiol promotes granulosa cell 
development by inhibiting FasL-induced apoptosis (Quirk et al., 2006), and the results 
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of the present study suggest that one mechanism of oestradiol action may be through the 
generation of NO.  
These findings can be placed in the context of follicle growth. In monovulatory 
species,  follicle growth occurs in waves, and a cohort of follicles arises in each wave. 
All but one of these follicles will become atretic, and the continued growth of the 
dominant follicle has been linked to increased IGF1 bioavailability and oestradiol 
production (Beg et al., 2002). This in turn would increase NO production and decrease 
the susceptibility of the cells to FasL mediated apoptosis. This scenario is supported in 
the present study by the higher levels of iNOS mRNA in the dominant, oestrogenic first-
wave follicle compared with subordinate non-oestrogenic follicles. Collectively, these 
data are consistent with a role for physiological levels of NO in the inhibition of 
apoptosis in granulosa cells. 
In summary, the present results demonstrate the expression and regulation of 
iNOS in bovine granulosa cells. Abundance of mRNA encoding iNOS is stimulated by 
FSH and IGF1 through increased oestradiol, and a blockade of oestradiol action 
consequently lowers iNOS mRNA levels. The present data suggest that endogenous NO 
production protects granulosa cells from apoptosis and consequently inhibits follicle 
atresia. 
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Fig 1. Effect of hormones and growth factors on abundance of iNOS mRNA and 
oestradiol secretion from granulosa cells in vitro. Cells were cultured for 6 days 
under non-luteinising conditions (see Materials and Methods for details), and 
treated with FSH (A), IGF1 (B), FSH with and without FGF2 (C) or IGF1 with or 
without EGF (D). Data are means ± SEM of three independent cultures. Bars with 
different letters are significantly different (P<0.05) 
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Figure 2. 
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Fig 2. iNOS mRNA abundance is stimulated by oestradiol.  A) Granulosa cells 
were cultured for 6 days under non-luteinising conditions with graded doses of 
FSH and either an aromatisable (A4) or non-aromatisable androgen (DHT). B)  
Granulosa cells were cultured in the presence of IGF1 (10 ng/ml) alone or with 
the antioestrogen, ICI 182,780 (10 μM); and FSH (1 ng/ml) alone or in the 
presence of ICI 182,780. C) Cells were cultured in the presence of the indicated 
doses of oestradiol (without FSH). Data are means ± SEM of three independent 
cultures. Asterisks denote differences between treatments (P<0.05), and bars with 
different letters are significantly different (P<0.05). 
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Figure 3. 
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Fig 3. Effects of an iNOS inhibitor on IGF1-stimulated granulosa cells in vitro. 
(A) Endogenous iNOS activity was inhibited with aminoguanidine (AG) and the 
abundance of mRNA encoding Fas ligand (FasL), levels of cleaved caspase-3 
protein and the proportion of apoptotic cells were measured. Data are means ± 
SEM of three independent cultures. Asterisks denote differences between 
treatments (P<0.05). (B) Representative culture showing nuclear staining (DAPI), 
cleaved caspase-3 fluorescence and brightfield images of the same clump of 
granulosa cells treated with IGF1 or IGF1 plus AG. 
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Figure 4.  
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Fig 4. Follicle size, oestradiol (E2) concentration and abundance of mRNA 
encoding aromatase (CYP19) and iNOS in six pairs of early dominant (D) and 
non-dominant (ND) follicles. The two largest follicles were collected from cows 
around the time of deviation in the first wave of the oestrous cycle. Data are 
means ± SEM of six cows. Asterisks denote differences between dominant and 
non-dominant follicles (P<0.05). 
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Abstract  
 
In rabbits and rodents, nitric oxide (NO) is generally considered to be critical for 
ovulation. In monovulatory species, however, the importance of NO has not been 
determined. The objectives of the present study were (1) to determine if nitric oxide 
synthase (NOS) enzymes are regulated by LH and (2) to determine if endogenous NO is 
critical for expression of genes essential for the ovulatory cascade in bovine granulosa 
cells (GC). We employed a short-term GC culture system in which epiregulin (EREG), 
amphireguln (AREG) and prostaglandin-endoperoxide synthase 2 (PTGS2) mRNA 
levels are acutely upregulated by LH. Time- and dose-response experiments 
demonstrated that LH had a significant stimulatory effect on endothelial NOS (NOS3) 
mRNA abundance but in a prostaglandin-dependent manner. NO production was 
stimulated by LH before a detectable increase in NOS3 mRNA levels was observed. 
Pretreatment of cells with the NOS inhibitor, L-NAME, blocked the effect of LH on the 
epidermal growth factor (EGF)-like ligands EREG and AREG, as well as PTGS2 
mRNA abundance and protein levels. Similarly, EGF treatment increased mRNA 
encoding EREG, AREG and the early response gene EGR1, and this was inhibited by 
pretreatment with L-NAME. Interestingly, pretreatment with L-NAME had no effect on 
either ERK1/2 or AKT activation. Taken together, these results suggest that endogenous 
NOS activity is critical for LH-induced ovulatory cascade in granulosa cells of a 
monotocous species and acts downstream of EGF receptor activation but upstream of 
the EGF-like ligands.  
Key words: ovary, nitric oxide, follicle, prostaglandins, ovulation 
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Introduction 
  
 Nitric oxide (NO) is a free radical gas generated within the cell by the 
conversion of L-arginine to L-citrulline by a family of nitric oxide synthases (NOS). 
Nitric oxide signaling and NOS activity modulate cellular functions in a number of 
organ systems, including the reproductive system, and particularly in the ovary. The 
predominant NOS enzymes present in female reproductive tissues are endothelial 
(eNOS, also known as NOS3) and inducible NOS (iNOS, also known as NOS2). A 
number of studies describe NOS activity in granulosa and theca cells of the ovarian 
follicle of several species and indicate that NO affects ovarian steroidogenesis, follicle 
development, apoptosis and oocyte maturation as well the ovulatory process [1]. 
 The involvement of NO in ovulation has been reported in different species. NO 
production is stimulated by hCG in follicular cells of rodents [2],  horses [3]  and rabbits 
[4]. The largest preovulatory follicle in the chicken also contains higher concentration of 
NO than smaller follicles [5]. In addition, it has been demonstrated that NOS inhibitors 
block hCG-induced ovulation in rats [6-8] and rabbits [4]. The importance of NO for 
ovulation in monovulatory species has not been established. Some studies in women 
undergoing in vitro fertilization report a positive correlation between NO levels in 
follicular fluid and size of preovulatory follicles [9]. In ruminants, although NO has 
been considered critical to oocyte maturation in cows [10-12], the role of NOS/NO 
system in ovulation has not been elucidated. 
 The ovulatory process is initiated by the surge of LH that leads to a cascade of 
events that culminates in the rupture of the follicle wall and release of the oocyte. A key 
element of this cascade is the secretion of prostaglandins (PG) by granulosa cells [13]. 
 
 
81 
 
Prostaglandins are synthesized by a LH-inducible enzyme, prostaglandin-endoperoxide 
synthase 2 (PTGS2, also known as COX2) [14]. It has been suggested that NO induces 
the ovulatory process through regulation of PG secretion. Inhibition of NO production 
reduced PG secretion and the administration of NO donors stimulated PG synthesis [2, 
4] at least in part by altering PTGS2 mRNA levels [15]. 
 In the last decade, it has been demonstrated that the LH-induced cascade leading 
to PTGS2 expression involves the EGF-like factors epiregulin (EREG) and 
amphiregulin (AREG). Briefly, LH induces the release of EREG/AREG from the 
surface of mural granulosa cells, which then act in an autocrine and paracrine manner to 
stimulate the EGF receptor of mural and cumulus cells. EGF receptor activation results 
in EREG/AREG expression and induction of PTGS2 expression [16, 17]. It is not 
known if NO affects EGF-like factor expression. 
 To better understand the involvement of NO in ovulation in monovulatory 
species, the objectives of the present study were (1) to determine if nitric oxide synthase 
(NOS) enzymes are regulated by LH and EGF, and (2) to determine if endogenous NO 
is critical for expression of genes essential for the ovulatory cascade in bovine granulosa 
cells. 
 
Materials and methods 
 
Cell culture 
The granulosa cell culture was as previously described [18] in which EREG, 
AREG and PTGS2 mRNA levels are acutely upregulated by LH. The reagents were 
obtained from Invitrogen except where otherwise stated. Briefly, bovine ovaries were 
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collected from adult cows, irrespective of stage of the estrous cycle, at a local abattoir 
and were transported to the laboratory in PBS at 35°C containing penicillin (100 IU/ml), 
streptomycin (100 μg/ml) and fungizone (1 μg/ml).  Five to eight ovaries that each 
contained a single large follicle (>10 mm diameter) were selected for each replicate. 
Cells were collected from the large follicle by aspiration, pooled and were washed twice 
by centrifugation at 219 x g for 20 min each. Cell viability was estimated with 0.4% 
Trypan Blue Stain. Cells were seeded into 24-well tissue culture plates (Sarstedt) at a 
density of 1 x 106 viable cells per well in 1 ml DMEM-F12 supplemented with sodium 
bicarbonate (10 mM), sodium selenite (4 ng/ml), BSA (0.1 %; Sigma-Aldrich), 
penicillin (100 IU/ml), streptomycin (100 μg/ml), transferrin (2.5 μg/ml), non-essential 
amino acid mix (1.1 mM), androstenedione (10-7 M), FSH (1 ng/ml), insulin (10 ng/ml) 
and 2% fetal calf serum (Hyclone). Cultures were maintained at 37°C in 5% CO2 for 24 
h. Medium was then replaced with serum-free DMEM-F12 with antibiotics for 18 h, at 
which point treatments were added for the times shown in Results. 
Cells were stimulated with bovine LH (AFP11743B; NIDDK), epidermal growth 
factor (EGF; R&D Systems) or prostaglandin E2 (PGE2; Sigma-Aldrich) at the doses 
and time periods described in Results, after which cells were recovered for analysis. In 
some experiments cells were treated 2 h before LH/EGF challenge with the nitric oxide 
synthase inhibitor Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME; Sigma-
Aldrich) or the prostaglandin synthesis inhibitor indomethacin (INDO; Sigma-Aldrich).  
 
Nucleic acid extraction & RT-PCR  
Total RNA was extracted using TRIzol (Invitrogen) according to the 
manufacturer’s instructions and quantified by absorbance at 260 nm. Total RNA (0.2 
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μg) was first treated with 1 U of DNase (Promega) at 37°C for 5 min to digest any 
contaminating DNA, followed by 65°C for 5 min for DNase inactivation. The RNA was 
reverse transcribed in the presence of 1 mM oligo(dT) primer and 4 U of Omniscript 
RTase (Omniscript RT Kit; Qiagen), 0.25 mM dideoxy-nucleotide triphosphate (dNTP) 
mix, and 19.33 U of RNase Inhibitor (GE Healthcare) in a volume of 20 Pl at 37°C for 1 
h. The reaction was terminated by incubation at 93°C for 5 min.  
Real-time PCR was performed in an ABI Prism 7300 instrument (Applied 
Biosystems, Foster City, CA) with Power SYBR Green PCR Master Mix (Applied 
Biosystems). Bovine-specific primer sequences were histone H2AFZ, PTGS2, EREG, 
AREG and STAR all in [18], NOS3 [19]  and NOS2 [20]. Common thermal cycling 
parameters (3 min at 95°C, 40 cycles of 15 s at 95°C, 30 s at 60°C and 30 s at 72°C) 
were used to amplify each transcript. Melting curve analyses were performed to verify 
product identity. Samples were run in duplicate, and were expressed relative to histone 
H2AFZ as housekeeping gene. Data were normalized to a calibrator sample using the 
Pfaffl ΔΔCt method with correction for amplification efficiency [21]. 
 
Western blotting  
After challenge with PGE2 (10 μM), LH (400 ng/ml) or EGF (5 ng/ml), with or 
without the NOS inhibitor L-NAME (100 μM), cells were harvested at different time 
points as described in the Results. For protein extraction, cells were washed with cold 
PBS and lysed in 100 μl/well cold RIPA buffer (25 mM Tris-HCL pH 7.6, 150 mM 
NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate, 
and protease and phosphatase inhibitor cocktails). The homogenate was centrifuged at 
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6000 g for 5 min at 4°C. The resulting supernatant was retained and stored at -20°C. 
Protein concentrations were determined by BCA protein assay (Pierce).  
Samples were resolved on 12% SDS-polyacrylamide gels (15 μg total protein 
per lane) and electrophoretically transferred onto PVDF membrane in a Bio-Rad wet 
Blot Transfer Cell apparatus (transfer buffer : 39 mM glycine, 48 mM Tris-base, 1% 
SDS, 20% methanol, pH 8.3). After transfer, the membranes were blocked in TTBS (10 
mM Tris-HCL, 150 mM NaCl, 0.1% Tween-20, pH 7.5) for 1 h then incubated 
overnight with the primary antibodies (anti-ERK, #9102, 1:1000; anti-phospho-ERK 
(Thr202/Tyr204), #9101, 1:1000; anti-AKT, #9272, 1:1000; anti-phospho-AKT 
(Ser473), #9271, 1:1000; all from Cell Signaling Technology) and anti-PTSG2 
(#160112, 1:1000; Cayman Chemical) diluted in TTBS at 4°C. After washing three 
times with TTBS, membranes were incubated for 2 h at room temperature with 1:20 000 
anti-rabbit (GE Healthcare) or with 1:200 000 anti-mouse (Calbiochem) horseradish 
peroxidase-conjugated immunoglobulin G diluted in TTBS. After five washes in TTBS, 
protein bands were revealed by chemiluminescence (ECL; Millipore) and 
autoradiography. Semiquantitative analysis was performed with NIH Image J software.   
 
Real time NO measurement  
 
Intracellular NO production was assessed with the fluorescent NO-sensitive dye 
4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM DA) essentially as 
described [22]. Cells were cultured as described previously, and pretreated with DAF-
FM DA (10 μM) 2 h before the addition of LH (400 ng/ml) or EGF (5 ng/ml). Cells 
were examined under an Olympus FV1000 laser-scanning confocal microscope at time 
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0 and 180 min. Digital images were captured from the same field and fluorescence 
intensity (ImageJ software) was assessed.  
 
Statistical Analysis 
 
All experiments were performed with three or four independent replicates, with 
each replicate using ovaries collected at different times. Replicates were usually 
performed at intervals of one week. Data that did not follow a normal distribution 
(Shapiro-Wilk test) were transformed to logarithms. Analysis of data was performed 
with JMP software (SAS Institute) with treatment and/or time as main effect and culture 
replicate (where appropriate) as a random variable in the F-test. Differences between 
means were tested with the Tukey-Kramer HSD test. Data are presented as means r 
SEM. 
 
Results 
 
The first series of experiments was performed to determine the regulation of 
NOS mRNA and activity by LH in bovine granulosa cells. A time-course experiment 
demonstrated that LH had a significant stimulatory effect on NOS3 and NOS2 mRNA 
abundance at 12 h post-challenge (P<0.05, Fig. 1A, B). Abundance of NOS2 mRNA 
was considered to be low owing to the high mean threshold Ct values for this mRNA 
(37-39) and this gene was not investigated further. The effect of dose of LH on 
abundance of mRNA encoding NOS3 and genes involved in the ovulatory cascade was 
then tested at the 12 h time point; LH significantly increased NOS3, EREG and AREG 
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mRNA levels (P<0.05, Fig. 2A). Further cultures demonstrated that EGF also stimulated 
NOS3, EREG and AREG mRNA levels at 6 h post-challenge (P<0.05, Fig. 2B).   
 As the peak for NOS3 mRNA abundance occurred only at 12 h after LH 
challenge, a relatively late time point in the LH-induced preovulatory cascade and that 
corresponds to the initial increase in prostaglandin secretion in vivo in cattle, we then 
tested whether prostaglandin regulates NOS3 expression. Addition of PGE2 stimulated 
NOS3 mRNA abundance (P<0.05, Fig. 3A). Moreover, when cells were pretreated with 
indomethacin, a non-selective PTGS inhibitor, EGF was not capable of increasing 
NOS3 mRNA levels (P<0.05; Fig. 3B). 
The effect of LH and EGF on NO production was then assessed with the NO-
sensitive dye, DAF-FM DA. The results indicated that both LH and EGF increased NO 
production 3 h after challenge (p<0.05; Fig. 4).    
A second series of experiments was then performed to assess whether NOS 
activity is critical for the expression of important genes involved in the ovulatory 
cascade. Challenge of cells for 6 h with LH increased EREG, AREG, PTGS2 and STAR 
mRNA levels, and pretreatment with the NOS inhibitor, L-NAME, effectively blocked 
the effect of LH on EREG, AREG and PTGS2, but not STAR mRNA abundance 
(P<0.05; Fig. 5A). Pretreatment with L-NAME also blocked the LH-induced increase in 
PTGS2 protein levels (P<0.05; Fig. 5B). L-NAME alone had no effect on basal gene 
expression. 
To further explore if NO is necessary for EGFR-dependent signaling, cells were 
pretreated with a single dose of L-NAME and challenged with EGF for 1, 2, 4 and 8 h. 
EGF alone increased mRNA encoding EREG and early growth regulatory factor-1 
(EGR1) within 1 h, and this was inhibited by pretreatment with L-NAME. EGF alone 
 
 
87 
 
also increased abundance of mRNA encoding AREG and the nuclear orphan receptors 
NR5A1 and NR5A2 after 8 h, and L-NAME inhibited the effect of EGF (P<0.05; Fig. 
6). 
To determine the site of action of NO, the effect of inhibition of NOS activity on 
ERK1/2 and AKT activation was measured by Western blotting. EGF stimulated 
ERK1/2 and AKT phosphorylation (Ser473 and Thr202/Tyr204, respectively), and 
pretreatment with L-NAME had no effect on either ERK1/2 or AKT activation (P>0.05; 
Fig. 7).  
 
Discussion 
 
 In rabbits and rodents, nitric oxide is generally considered to be necessary for 
ovulation, and acts in part through increased prostaglandin secretion. In monovulatory 
species, however, the importance of nitric oxide has not been determined. In the present 
study, we employed an in-vitro model of preovulatory events in cattle to provide the 
first evidence that nitric oxide is necessary for the preovulatory cascade in a monotocous 
species, that this likely involves very early generation of nitric oxide not requiring 
transcriptional activation of NOS enzyme genes, and that the locus of action of nitric 
oxide is the EGF-like factors EREG and AREG. 
 In the present study we detected an increase of both NOS3 and NOS2 mRNA 
levels in granulosa cells after treatment with LH. Nevertheless, NOS2 was detected at 
very low levels and was not investigated further. The presence of NOS2 and NOS3 and 
their regulation by gonadotropins has been examined in the rat ovary by several authors, 
but the contribution of each NOS to ovulation is still not clear. One of these studies 
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found that NOS2 protein was barely detectable during follicle development and the 
ovulatory process [23]; other reported maximal levels of NOS2 mRNA in unstimulated 
ovaries and its reduction after hCG injection [24].  An increase of both NOS2 and NOS3 
after hCG stimulation has been reported [25, 26]. On the other hand, a more recent study 
demonstrated the presence of only NOS3 protein levels in the ovary of rats 10 h after 
hCG treatment [27]. Moreover, studies with NOS2-and NOS3-knockout mice indicated 
that disruption of NOS2 had no effect on ovulation rate in superovulated prepubertal 
females, but NOS3 deficiency had a significant negative effect [28, 29]. Although little 
is known about NOS regulation in GC during the preovulatory period in ruminants, 
recently our group published a study determining the regulation of NOS2 in bovine GC 
during follicular development, suggesting that NOS2 expression is estradiol-dependent 
[20]. The decline in circulating estradiol levels during the periovulatory period [30]  
could explain the NOS2 low mRNA abundance in the preovulatory model used in the 
present study. 
 Our results demonstrate that LH stimulated NOS3 mRNA levels around 12 h 
post-challenge, which is a fairly late event in the preovulatory cascade. This increase 
coincides with LH-dependent PTGS2 mRNA expression in this culture system [18] and 
to increased PG secretion in vivo after the LH surge [31]. This suggests that NOS3 
mRNA may be regulated by PG, and that any role that NO plays in the induction of 
ovulation is not likely due to transcriptional activity of the NOS3 gene, which we 
confirmed by direct stimulation of NOS3 mRNA levels with PG and by the ability of the 
PTGS2 inhibitor indomethacin to abrogate the effect of EGF on NOS3 mRNA levels. 
These results are supported by reports showing that PGE2 induces NOS3 expression in 
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cerebral microvessel endothelial cells in pigs [32] and that PGF2α induces NOS3 
expression in bovine corpus luteum [33].   
 It has been also reported that NOS activity increases in the period that precedes 
ovulation in other species. The intracellular NO measurement performed in our study 
indicated that NO production was increased in GC in the first 3 hours after LH/EGF 
challenge. These results support the hypothesis that NOS3 may be the most important 
 NOS acting in our preovulatory model: while NO generation from NOS2 depends 
almost exclusively on the transcriptional increase of this enzyme, NO generation can 
rise as a consequence of NOS3 activation even before a significant increase of its 
expression levels. In hepatocytes of mice it was shown that EGF-induced NOS3 
activation is dependent on the EGFR/PI3K/AKT signaling [34]. In human epidermal 
keratinocyte cell line, HB-EGF-induced NOS3 activation depends on both ERK1/2 and 
PI3K/AKT pathways [35]. However, whether LH activates NOS3 in a manner 
dependent or independent of EGFR signaling in our cell model is still unknown.  
Interestingly, NOS3 can be also activated by calcium increase [36], and in swine GC it 
was demonstrated that LH induces a rapid and biphasic rise in calcium [37]. 
 The NO generated from NOS activation appears to be critical in the preovulatory 
period. Although a recent study suggests that NO inhibits oocyte maturation and 
ovulation in rats [8], it has been demonstrated that knockout of the NOS3 gene severely 
impairs both oocyte maturation and ovulation in mice [28, 29, 38] and that NOS 
inhibitors suppress hCG-induced ovulation in rats [6, 7] and rabbits [4]. Some of these 
studies also used NO-generating drugs (NO donors) to stimulate or restore ovulation; 
however, these data should be interpreted with caution as NO donors have been shown 
to be cytotoxic [39, 40]. Some authors suggest that the positive relationship between NO 
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and ovulation is related to a crosstalk between NO and PG secretion. Inhibition of NO 
production reduced ovarian prostaglandins synthesis in rats and rabbits [2, 4]. It was 
shown in different cells types that NO may stimulate PTGS2 mRNA levels and PTGS2 
activity directly. NO interacts with various pathwayswhich can influence PTGS2 
expression such as the B-catenin/TCF, cAMP/PKA/CREB and JNK/Jun/ATF2 signaling 
cascades [15]. NO also activates PTGS2 by binding directly to its heme group [41]. Our 
results confirm that inhibition of NOS activity reduces mRNA and protein levels of 
PTGS2 in preovulatory granulosa cells of cattle. 
 LH induces PTGS2 expression in GC by stimulating the release of the EGF-like 
ligands, EREG and AREG. These activate the EGF receptor and its downstream 
signaling that includes a positive feedback on EREG and AREG expression [42]. A 
previous study from our group using the same cell culture system demonstrated that LH 
increased EREG mRNA levels within 1 h and AREG mRNA levels 6 h after challenge 
[18]. Our present results clearly indicate that inhibition of NOS activity effectively 
blocked the effect of LH on EREG, AREG and PTGS2 mRNA abundance after 6 hours. 
Similarly, inhibition of NOS activity effectively reduced the ability of EGF to induce 
EREG and AREG expression. To our knowledge, this is the first report that indicates the 
expression of EGF-like factors is NO-dependent.  
 The EGF receptor (EGFR) activation is essential to the signaling cascade that 
leads to PTGS2 expression, which entails activation of the ERK1/2 and AKT kinase 
cascades [43, 44]. We demonstrated in this study that L-NAME affected 
EREG/AREG/PTGS2 expression but did not affect ERK1/2 or AKT activation. 
Inhibition of NOS activity affected expression of the early-response gene EGR1 that, 
like EREG and AREG, is ERK1/2-dependent [45]. Although not conclusive, these 
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results suggest that NO must be critical downstream of ERK1/2 signaling but upstream 
of EGR1 and the EGF-like ligands. Different transcriptional regulators are known 
toaffect ovulation and appear to help mediate the effects initiated by ERK1/2. Mice 
lacking nuclear receptor–interacting protein 1 (Nrip1; also known as RIP140) exhibit 
impaired ovulation and reduced expression of EREG, AREG, and other ovulation-
related genes [46]. RIP140 could be a potential target of NO in this preovulatory system. 
Taken together, these results suggest that the LH surge induces granulosa cells to 
activate NOS; NOS activity induces production of NO, which is essential for 
EREG/AREG/PTGS2 expression. In conclusion, NOS activity is critical for LH-induced 
ovulatory cascade in granulosa cells and NO may be essential for ovulation in cattle.  
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Fig. 1. LH induces NOS mRNA abundance in a time-dependent manner. Bovine 
granulosa cells from large follicles (≥10 mm diameter) were cultured with serum for 24 
h, and then in serum-free medium for a further 18 h, before adding LH (400 ng/ml) for 
the times given. Messenger RNA abundance was measured by real-time PCR. Data 
represent the mean ± SEM for three independent replicate cultures. LH-stimulated data 
are expressed relative to the control data at each time point. An asterisk (*) denotes 
significant increases over control (P ˂ 0.05). 
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Figure 2. 
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Fig 2. NOS3 mRNA levels are regulated in a dose-dependent manner by LH and EGF. 
Cells were cultured as described in the legend for Figure 1 and were treated for 12 h 
with the indicated doses of LH (A) and for 6 h with the indicated doses of EGF (B). 
Messenger RNA abundance was measured by real-time PCR. Data represent the mean ± 
SEM for three independent replicate cultures. Asterisks (*) denote differences between 
treatments (P<0.05). 
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Figure 3. 
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Fig. 3. Prostaglandins regulate NOS3 mRNA levels. Bovine granulosa cells were 
cultured as described in Figure 1. (A) Effect of treatment for 6 h with the indicated 
doses of PGE2 and EGF. (B) Effect of pretreatment with indomethacin, a nonselective 
PTGS inhibitor on NOS3 mRNA abundance 6 h after challenge with EGF. Messenger 
RNA abundance was measured by real-time PCR. Data represent the mean ± SEM for 
three independent replicate cultures. Asterisks (*) denote differences between treatments 
(P<0.05). 
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Figure 4.  
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Fig. 4. LH and EGF increase nitric oxide production. Intracellular NO production was 
assessed with the fluorescent NO-sensitive dye DAF-FM DA. Cells were cultured as 
described previously, and pretreated with DAF-FM DA (10μM) 2 h before the addition 
of LH (400 ng/ml) or EGF (5 ng/ml). Cells were examined under laser-scanning 
confocal microscope at time 0 and 180 min. Digital images were captured from the same 
field and fluorescence intensity was assessed. Data represent the mean ± SEM for three 
independent replicate cultures. An asterisk (*) denotes significant increases over control 
(P ˂ 0.05). 
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Figure 5.  
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Fig. 5. Effect of NOS inhibitor on LH-induced preovulatory genes. Bovine granulosa 
cells were cultured as described in Figure 1. Cell were treated with different doses of L-
NAME, a NOS inhibitor, on abundance of mRNA encoding genes involved in the 
ovulatory cascade at 6 h after LH challenge (A) and on PTGS2 protein levels at 12 h 
after LH (400 ng/ml) challenge (B). Protein secretion was measured by western blot and 
a blot of one independent culture is shown with the samples in the same order as in the 
graph. Messenger RNA abundance was measured by real-time PCR. Data represent the 
mean ± SEM for three independent replicate cultures. Bars with the same letters are not 
significantly different (P ˃ 0.05). 
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Figure 6.  
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Fig. 6. Effect of NOS inhibitor on EGF-induced preovulatory genes. Bovine granulosa 
cells were cultured as described in Figure 1 and were pretreated with L-NAME (100 
μM), a NOS inhibitor, before EGF (5 ng/ml) challenge. Messenger RNA abundance was 
measured by real-time PCR. Data represent the mean ± SEM for three independent 
replicate cultures. An asterisk (*) denotes significant increases over control at each time 
point (P ˂ 0.05). 
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Figure 7. 
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Fig. 7. Nitric oxide is not essential for EGF-induced ERK1/2 and AKT phosphorylation. 
Bovine granulosa cells were cultured as described in Figure 1. In the presence of 
different doses of L-NAME, EGF was able to induce ERK1/2 and AKT 
phosphorylation. Samples were collected 15 min after EGF challenge to measure 
phosphorylation by western blot, and the blot of one independent culture is shown with 
the samples in the same order as in the graph. Cells from the same pools were pretreated 
with different doses of L-NAME and challenged for 6 h with EGF to confirm L-NAME 
effects on abundance of mRNA encoding genes involved in the ovulatory cascade in 
granulosa cells. Data represent the mean ± SEM for three independent replicate cultures. 
An asterisk (*) denotes significant increases over control (P ˂ 0.05). 
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General discussion 
 
             Disorders of ovarian function are major causes of infertility, subfertility and 
cancer. A better comprehension of the regulation of granulosa cell function is likely to 
be critical in resolving the cause of several ovarian disorders, as well overcoming 
ovarian follicle ageing and improving the success rate of assisted reproductive 
technologies. Models for granulosa cells culture are of considerable interest, especially 
animal models. Ruminants, particularly cattle, offer great potential, not only because of 
the agricultural importance of this species, but also its potential use as a model for 
humans. Many aspects of follicle growth in cows are similar to those in humans. Both 
species are predominantly mono-ovulatory, and sizes of follicles at different stages of 
development are similar [283]. The dynamics of follicle wave emergence appear to be 
similar in cows and women [33, 284], and reproductive ageing in cattle and women 
share many features [285].       
 Events associated with the normal progression of proliferation and 
differentiation of granulosa cells are critical for growth of the follicle, health of the egg 
and the process of ovulation. Granulosa cell health and death are regulated by endocrine 
factors such as gonadotropins, paracrine growth factors and intracrine modifiers of cell 
function. The free radical gases comprise a group of intracrine agents that have been 
linked to ovarian function. One of these is nitric oxide (NO). This short-lived gas is 
produced by the action of the enzymes nitric oxide synthase (NOS), and has several 
effects on cell function. 
            The regulation of NOS and the contribution of NO for the follicle growth and the 
ovulatory processes in cattle were until now unclear. Together, the novel results reported 
in this thesis not only indicate that bovine granulosa cells express NOS2 and NOS3, but 
also demonstrate a difference in the pattern of expression/activity of these enzymes 
throughout  follicle growth in the cow. The NO generated by the activity of each of 
these enzymes seems to exert important functions at least in two distinct physiological 
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moments. During the establishment of follicle dominance, NO seems to be a critical 
anti-apoptotic agent produced by granulosa cells to avoid atresia. On the other hand, in 
the preovulatory period, NO seems to act as an essential mediator of the ovulatory 
cascade. 
  The above mentioned results were obtained using different cell models and in 
vivo samples carefully selected to represent granulosa cells at different stages of 
development. In the first article of this thesis, the objectives were to gain insight into the 
expression and role of NOS2 during follicle growth in cattle. For this, granulosa cells 
from follicles between 2-6 mm were cultured in serum-free conditions. In this 
nonluteinizing model, the cells retain their typical follicular (estrogenic) phenotype and 
responsiveness to FSH and IGF1, but not LH [23, 28, 286]. Herein, this model will be 
described as the differentiation model. Preliminary results indicated that mRNA levels 
for both NOS2 and NOS3 were detected in granulosa cells cultured in this model. 
However, for the first article we decided to focus only on NOS2, because it is known to 
be inducible in a large number of cell types, whereas the others are generally expressed 
constitutively  [263]. Another relevant criteria for this choice was the fact that in a cell 
that expresses more than one NOS, NOS2 presents a higher contribution to NO 
generation [169, 172, 173]. While NOS3 is commonly associated with basal production 
of NO (nM), NOS2 activity may generate NO at more elevated levels (μM).   
        For the second article of this thesis the objectives were to determine the regulation 
pattern of NOS during the preovulatory period and to determine if endogenous NO is 
essential for expression of genes critical for the ovulatory cascade in bovine granulosa 
cells. A second in vitro bovine model was then employed, in which cells from large 
follicles (>10mm) are conditioned with FSH then challenged with LH or EGF; both 
induce the expression of genes involved in ovulation, including EREG, AREG, PTGS2 
and others [95]. As this model can simulate in vitro the LH-induced ovulatory cascade 
in bovine granulosa cells, it will be described here as the periovulatory model. The first 
series of experiments using this second model also demonstrated the expression of both 
NOS2 and NOS3. But surprisingly, NOS2 levels were lower than expected. A time-
  
112 
 
course experiment demonstrated that LH had a significant stimulatory effect on NOS3 
and NOS2 mRNA abundance at 12 h post-challenge (figure 1; chapter 3; article 2). 
Abundance of NOS2 mRNA was considered to be low owing to the high mean threshold 
Ct values for this mRNA (37-39 cycles). The high mRNA abundance for NOS2 detected 
in all the experiments performed with the differentiation model was not verified in the 
periovulatory model. These results suggest that NOS expression pattern changes 
throughout the follicle growth in cattle. In sheep, it was demonstrated that NOS3 protein 
and mRNA expression changes substantially during follicular growth. NOS3 mRNA 
levels increased in granulosa cells at 12 and 24 h after hCG treatment [276]. In swine it 
was demonstrated that NOS3 levels increase in late stages of follicle development and 
the authors suggested that these changes might be related to the gonadotropins surge and 
necessary to the ovulation in this species [277]. In rats, NOS2 and NOS3 are also 
differentially regulated during follicular  development [264]. 
 In the first article, the differentiation model employed was used to mimic in vitro 
the conditions of a growing follicle. In this model, FSH and IGF1 stimulate cell 
proliferation and estradiol secretion [28, 287]. When we challenged granulosa cells with 
graded doses of FSH and IGF1, there was stimulation on estradiol secretion and NOS2 
mRNA abundance (Figure 1; chapter 3; article 1). To complement these results, we 
determined if NOS2 mRNA abundance would differ between growing and non-growing 
follicles using a well-defined in vivo model described in the article 1. The results 
indicated that NOS2 abundance was higher in growing dominant follicles compared to 
subordinate follicles. The status of the dominant follicle was confirmed by higher 
estradiol concentrations and CYP19 mRNA abundance (figure 4; chapter 3; article 1). 
As in both in vivo and in vitro models NOS2 expression was positively correlated with 
estradiol levels, we then decided to determine if estradiol had a direct effect on NOS2 
mRNA. In fact, the addition of an anti-estrogen prevented FSH- and IGF1-induced 
NOS2 mRNA accumulation. In addition, estradiol alone significantly increased NOS2 
mRNA abundance (figure 2; chapter 3; article 1). This data clearly show that NOS2 
expression in bovine granulosa cells is, at least in part, estradiol-dependent. This could 
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explain the lower NOS2 mRNA levels detected in granulosa cells used in the 
periovulatory model. In this model, CYP19 levels decrease in a time-dependent manner 
and, consequently estradiol secretion decrease with time (data not shown). This is 
supported by the fact that circulating estradiol levels decline during the peri-ovulatory 
period in vivo [288]. So, the NOS2 increase observed at 12 h post LH-challenge in our 
periovulatory model was probably stimulated in a different manner than the estradiol-
dependent stimulation verified in the differentiation model.  
 The different pattern of NOS2 and NOS3 gene expression detected in both 
articles 1 and 2, suggests that the amount of NO required by the follicle during its 
growth in cattle may change. Although in the first article NOS3 regulation was not 
studied, it was clearly demonstrated by different experiments that NOS2 mRNA levels 
increased in healthy growing follicles. In cattle, the dominant follicle is characterised by 
a healthy layer of granulosa cells growing under the influence of IGF [289]. Our studies 
using the differentiation model indicated that NOS2 mRNA abundance is stimulated in a 
dose-dependent manner by IGF1 (figure 1; chapter 3; article 1). To confirm our in vitro 
findings, we demonstrated with in vivo samples that NOS2 abundance was higher in 
growing dominant follicles compared to subordinate follicles (figure 4; chapter 3; article 
1). Supported by the literature of NO as an anti-apoptotic agent in several cells types, 
including granulosa cells [227, 229], we decided to determine if NOS2 
expression/activity was one of the mechanisms used by dominant growing follicles to 
avoid atresia. As we hypothesized, endogenous NOS2 activity inhibited apoptosis in 
bovine granulosa cells. Using the differentiation model, granulosa cells were cultured 
with IGF1 with or without the selective NOS2 inhibitor, aminoguanidine. Addition of 
aminoguanidine increased the abundance of mRNA encoding the pro-apoptotic factor 
Fas ligand, cleaved caspase-3 protein and, consequently, the proportion of apoptotic 
cells (figure 3; chapter 3; article 1). 
 Overcoming atresia by a dominant follicle is a critical process and is dependent 
of the balance between death and survival factors. Among the survival factors is 
estradiol, the hallmark of follicle health. Estradiol is a well known anti-apoptotic factor 
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that acts in different manners to inhibit apoptosis [19]. The results from our first article 
suggest that one of the mechanisms by which estradiol combats apoptosis in granulosa 
cells and guarantees follicle dominance is through NO generation. The fact that during 
the dominant follicle growth NOS2 is more highly expressed than in granulosa cells 
from preovulatory follicles, suggests that the amount of NO necessary to inhibit 
apoptosis is larger than the amount necessary to mediate the ovulatory cascade. 
 In terms of NOS gene expression regulation, results obtained in the article 2, 
using the periovulatory model, demonstrate that NOS3 is transcriptionally regulated by 
LH. Although the time-course experiment with LH suggested that the mRNA increase in 
NOS3 was a relatively late event in the preovulatory cascade, the experiments using the 
NOS activity inhibitor L-NAME indicated that NO generated in the first hours after LH 
challenge was essential for the expression of important preovulatory genes like EREG 
and AREG (figure 5; chapter 3; article 2). These results demonstrate that NO generated 
at lower levels by basally expressed NOS3 enzymes is essential for LH-induced 
signaling cascade. A similar effect could be observed when cells were challenged with 
EGF with or without L-NAME. Although we did not study the mechanisms of 
activation of NOS3 in the first hours after LH or EGF treatments, our results indicated 
that NO production increased in bovine granulosa cells in the first 3 hours after 
challenge (Figure 4; chapter 3; article 1). These results suggest that NOS3 is post-
translationally regulated in our periovulatory model and that NO produced by this initial 
regulation is critical for the early events of the ovulatory cascade. Although not verified 
in our studies, it is known that phosphorylation of NOS3 at specific residues causes the 
enzyme to produce higher levels of NO [169]. 
 In support of the importance of NOS3 activity, the blockage of NOS3 with L-
NAME resulted in the inhibition of PTGS2 mRNA levels at 6 h and PTGS2 protein 
levels at 12 h after LH challenge (figure 5; chapter 3; article 2). Interestingly, PGs alone 
stimulated NOS3 mRNA abundance (figure 3; chapter 3; article 2), indicating the 
existence of a positive feedback loop between NO and PGs; and potentially explaining 
the late increase in NOS3 mRNA levels observed only at 12 h post-LH. The biological 
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actions of prostaglandins have been attributed to their interaction with cell surface G 
protein–coupled receptors, FP for PGF2α and EP2, EP3, and EP4 for PGE2. Both EP2 
and EP4 receptors typically couple to Gs to increase dramatically and immediately 
cAMP levels in the cytoplasm [32]. In bovine, the LH/FSH surge also modulates the 
levels of mRNA for PGs receptors. In granulosa cells, mRNA levels for EP2 increase 
post-GnRH and remain elevated. In contrast, early in the periovulatory period, while 
EP4 mRNA levels increase transiently, EP3 mRNA levels decrease transiently [76]. In 
swine cerebral microvascular endothelium, it has been reported that PGE2 increase 
NOS3 expression via EP3 receptors. More importantly, in addition to plasma membrane 
EP3 receptors, in the same cells mentioned above it has been also demonstrated the 
presence of functional perinuclear EP3 receptors for PGE2. The stimulation of the 
perinuclear EP3 receptor can induce the expression of NOS3, a process that depends on 
nuclear envelope KCa channels, protein kinases, and NF-ƘB [32].  
 Together the results presented in the 2 articles presented in this thesis confirm 
our hypothesis that different amounts of NO may be required at different times during 
follicle development in cattle. It is possible to suggest a “switch” between NOS2 and 
NOS3. During the establishment of follicle dominance, the high concentration of NO 
produced from NOS2 expression/activity seems to be crucial, but in the periovulatory 
period, especially in the early events of preovulatory cascade, lower levels of NO 
generated from NOS3 activity may play a very important role. Although we do not have 
absolute values for NO produced in each cell model evaluated, the literature indicates 
different amounts produced by the activity of each NOS, with NOS2 responsable for the 
highest production [169, 172].    
 In terms of mechanisms of action, in both article 1 and 2 we decided to use only 
NOS inhibitors (aminoguanidine and L-NAME, respectively). These are competitive 
inhibitors  and produce a time-dependent inactivation of  NO generation [220]. It means 
that in terms of NO action on granulosa cells, our results are simply based in the 
evaluation of the consequences of reduction/inhibition of NO generation. Although 
useful experiments would require also the addition of NO directly to our models, as NO 
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is a free radical gas, it is difficult to reproduce physiological intracellular concentrations 
of NO. Many authors employ exogenous NO donors in their experiments. Although 
useful, NO donors must be used with extreme caution because some of them easily 
reach cytotoxic levels [213, 252]. Moreover, NO may exert different roles according to 
concentration. A good example comes from studies of the effects of NO in cancer, 
showing that NO either promotes or inhibits tumorigenesis. These conflicting findings 
have been resolved, in part, by the levels of NO donors used such that low levels 
promote tumor growth and high levels inhibit tumor growth [193]. To reproduce a 
similar amount of NO produced endogenously by granulosa cells in our differentiation 
and periovulatory models would require precise measurement of NO concentrations and 
a detailed search for the more appropriated NO donor and the optimization of its use. 
 Many of the physiological functions of NO seem to be mediated by cGMP [290]. 
So, an interesting alternative to test NO effects on granulosa cells in our models could 
be the use of cGMP analogs and/or drugs that inhibit cGMP generation in response to 
endogenous NO. However, studies with bovine granulosa cells and COCs indicated that 
some of the effects exerted by NO (NO donors) on granulosa cell steroidogenesis, as 
well oocyte maturation can be cGMP-independent [212, 251]. As NO could be acting by 
more than one mechanism and interacting with different molecules in each of our 
models we preferred to use only NOS inhibitors and correlate our results with NOS 
expression/activity patterns and NO generation profile.  
 The information about NOS regulation and NO function presented in this thesis 
may be extremely useful for the development or improvement of drugs or techniques to 
control or improve the efficiency of NO signaling. Pharmacological therapies target 
increased NO bioavailability by influencing the activity of endogenous NOS. This can 
be achieved by oral tetrahydrobiopterin (BH4) supplementation for example [291]. 
Besides the supplementation with co-factors crucial for the NOS enzymatic reaction, 
supplementation with the substrate L-aginine as a therapeutic approach may also 
represent an interesting option. A study with poor responder women concluded that oral 
L-arginine supplementation may improve ovarian response, endometrial receptivity and 
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pregnancy rate [292]. Interestingly, prolonged treatment with N-acetylcysteine and L-
arginine restores gonadal function in patients with polycystic ovary syndrome [293].  
 NO levels can also be raised by using NO-releasing donor compounds. Several 
studies have demonstrate that dietary supplementation with NO donors induce benefits 
in exercise performance, for example [294]. NO donors represent useful means of 
systemic NO delivery and have been used for many years as effective therapies for 
many disorders [295]. However, as mentioned previously, the use of exogenous NO 
donors must be done with extreme caution and optimisation of the delivery compound is 
an essential step required to avoid systemic toxicity and side effects [296]. 
Nanotechnology has benefited a number of biomedical areas including drug delivery. 
The use of nanostructured materials, like nanoparticles, as drug delivery systems has 
begun to impact medicine due to beneficial size-dependent physical and chemical 
properties [297]. Nitric oxide-releasing nanoparticles have presented promising results 
in the acceleration of wound healing [298, 299], antimicrobial efficacy [300] and on the 
inhibition of ovarian cancer cell growth [301].  
 Other existent technique to manipulate NO system involves gene therapy. 
Research has concentrated on comparing the effect of gene delivery of NOS enzymes in 
healthy and diseased animal models. In intimal hyperplasia, restenosis, vascular tone 
and ischemia-reperfusion injury, for example, most results demonstrate therapeutic 
benefits following vascular gene delivery of all NOS in pre-clinical models of 
cardiovascular disease [302]. The focus of gene therapy has been to deliver the NOS 
gene directly to the site of injury resulting in a local increase of NO generation. This 
approach avoids the problem with systemic NO toxicity. The direct delivery of NOS 
genes to the follicle, especially granulosa cells, could be a tool to solve problems with 
follicle growth and anovulation. 
 Although in this thesis we did not the mechanism used by NO to inhibit 
apoptosis in the growing dominant follicle or mediate the ovulatory cascade in cattle, we 
clearly identified genes and proteins affected by NO reduction/absence. These data 
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indicate the importance of NO for the follicle development and growth; and reveal novel 
direct or indirect NO targets in granulosa cells. An emerging pathway for NO action is  
S-nitrosylation. This process is the direct modification of proteins by adding a NO 
moiety to the amino acid cysteine [190, 192]. The impact of S-nitrosylation in healthy 
and diseased ovaries is unknown. Future studies involving the identification of proteins 
S-nitrosylated during the follicle dominance establishement and ovulation may permit 
the selection of potential targets and/or mechanism to be manipulated with the objective 
of improving fertility efficiency or even combat ovarian disorders in cattle and women.  
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Final conclusions  
 
 In conclusion, the studies reported in this thesis not only confirm the presence of 
an active nitric oxide system in bovine granulosa cells, but also demonstrate that nitric 
oxide synthase expression and activity are regulated by gonadotropins, estradiol and 
growth factors throughout follicle development and growth in cattle. Physiological 
levels of nitric oxide contribute to the survival of granulosa cells, exerting an important 
role in the establishment of follicle dominance. Moreover, NOS activity seems to be 
critical for the LH-induced ovulatory cascade in granulosa cells and NO may be 
essential for ovulation in cattle. We provide novel insight regarding the role of NO 
upstream of PTGS2. To our knowledge, this is the first study indicating an interaction 
between NO and EGF-like factors during the preovulatory period.   
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